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Obsesity, the excess deposition of white adipose tissue, is a growing problem in 
the U.S. and other developed countries.  Formerly thought to be inert, adipose tissue is 
now recognized as a dynamic endocrine organ with its secretion of adipokines and a 
newly proposed class hormone class “lipokine”.  Adipocytes are the functional unit of 
adipose tissue and can influence the tissue through hyperplasic and hypertrophic growth.  
In order to investigate the mechanisms involved in adipogenesis and lipogenesis of 
adipose tissue, stromal vascular cultures were isolated from adipose tissue of finishing 
cattle for use in experiments.   
There is a positive relationship between lipogenic gene expression and increased 
energy in steer diets.  The objectives of the studies presented in Chapter 2 were to 
determine if differences in fatty acid profiles or gene expression exist when adipocytes 
are exposed to different, simulated energy sources:  linoleic acid, insulin, or both 
following differentiation.  With limited information in the literature about the timing of 
lipid uptake and fatty acid composition in differentiating bovine adipocytes, a secondary 
objective of these studies was to evaluate fatty acid composition over time.  Overall, 
results from these studies indicate that fatty acid composition changes over time post-
differentiation and is modulated by linoleic acid supplementation.  Expression of SCD1 
mRNA was up-regulated prior to changes in fatty acid desaturation profiles.  In addition, 
linoleic acid treatment was incorporated into cells and its supplementation decreased 





Recent evidence links palmitoleic acid to decreased lipogenesis in murine 
hepatocytes.  Since adipocytes are the primary site of lipogenesis in ruminants, the 
objectives of the experiment in Chapter 3 was to determine if a similar effect could be 
seen in bovine adipocytes and titrate an effective dose of palmitoleic acid 
supplementation.  Concurrent with palmitoleic acid, cis-vaccenic (C18:1 cis-11) and 
eicosenoic (C20:1 cis-13) acids increased linearly with palmitoleic acid supplementation 
in bovine adipocytes.  In addition, activity and mRNA expression of several lipogenic 
genes were down-regulated and -oxidation was increased in response to palmitoleic acid 
supplementation.  Therefore, palmitoleic acid was having an anti-lipogenic effect on the 
bovine adipocyte cultures.   
The elevated presence of suspected elongation products of palmtioleic acid, cis-
vaccenic and eicosenoic acids, in cultures supplemented with palmitoleic acid left doubt 
as to which fatty acid contributes to anti-lipogenic effects.  The objectives of the studies 
performed in Chapter 4 were to confirm cis-vaccenic and eicosenoic acids as elongation 
products of palmtioleic acid using a stable isotope tracer and test lipogenic effects of cis-
vaccenic acid.  Cis-vaccenic and eicosenoic acids are, indeed, direct elongation products 
of palmtioleic acid.  In addition, cis-vaccenic acid decreased lipogenesis rates, but did not 
affect desaturation.  Therefore, palmitoleic acid differentially affects aspects of 
lipogenesis relative to its elongation products.  Overall, the results of this work advance 
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CHAPTER 1:  FATTY ACIDS IN RUMINANTS 
 
INTRODUCTION 
Nutrition plays an integral role in animal production systems; it impacts 
maintenance, growth, health, and reproduction.  Maximizing efficiency and optimizing 
nutrient partitioning of the diet are economical goals of most producers.  An animal‟s 
excess energy is stored as fat in adipocytes, which are the functional, energy-storage units 
of the body.  Fat has both positive and negative aspects for producers.  In the beef 
industry, USDA grading standards estimate cutability and eating quality of the lean tissue 
to determine carcass value.  Yield and quality grades applied to beef carcasses are highly 
influenced by the abundance of subcutaneous and intramuscular fat, respectively.  Excess 
subcutaneous fat can decrease carcass value in addition to wasting dietary energy, an 
estimated financial loss of $1.3 billion annually (National Beef Quality Audit, 2000).  
However, intramuscular fat, or marbling, is an estimate of eating quality of the meat and 
usually results in a premium price.  Tenderness, the key determinant of a steak‟s eating 
quality, is associated with marbling.  In addition, consumers prefer steaks that are high in 
marbling rating them better in terms of juiciness, flavor, and overall acceptability than 
steaks of the same tenderness level with low marbling scores (Killinger et al., 2004).   
Therefore, the abundance of fat in meat products has financial and health implications to 
both producers and consumers. 
The composition of fat in animal products is also important to consumers and 
producers.  Meat and milk are the primary end-products of economic importance in 





species-determination, can be greatly affected by fatty acid composition.  Health 
concerns have arisen in recent years regarding fatty acid composition of animal products 
in the human diet.  In general, saturated fatty acids (SFA) in the human diet are 
associated with elevated cholesterol levels (Hegsted et al., 1965), an exception being 
stearic acid (C18:0) (Denke and  Grundy, 1991).  However, monounsaturated fatty acids 
(MUFA) and polyunsaturated fatty acids (PUFA) in the human diet can reduce serum 
cholesterol levels (Mattson and  Grundy, 1985; Table 1).  The composition and quantity 
of white adipose tissue found in meat is greatly influenced by the animal‟s nutrition.  For 
instance, cattle finished on grain have greater MUFA in intramuscular fat compared with 
cattle finished on forage, which have greater C18:0 and PUFA (Williams et al., 1983).  
The time on feed can also impact quantity and composition of intramuscular fat in cattle 
(Duckett et al., 1993).  During the finishing-stage in cattle production, approximately 14 
to 18 mo. of age, intramuscular fat deposition is the result of both hyperplasia, increase in 
cell number, and hypertrophy, increase in cell size (Hood and  Allen, 1973).  Although 
cell number and size both increase during animal maturation, 70% of fat accumulation is 
the result of hypertrophy (Robelin et al., 1985) with most hyperplasia of subcutaneous 
and perirenal adipose depots complete by 8 mo. of age (Hood and  Allen, 1973).  
Preadipocytes, cells responsible for hyperplasia, are of mesenchymal lineage and have 
the ability to propagate or commit to differentiation (Gesta et al., 2007).  With an increase 
in excess energy, preadipocytes differentiate into mature adipocytes, which have the 





biotechnology strategies, or both to alter abundance and composition of adipose tissue 
could improve production efficiency and quality of meat.  
Prior to the discovery of leptin (Zhang et al., 1994), the primary effector of 
satiety, white adipose tissue was thought to be solely an energy-storage unit, inert, with 
no metabolic function as reviewed by  McGillis (2005).  Since then, adipokines, such as 
adiponectin, have been discovered as cell-to-cell signaling hormones which are 
exclusively expressed by adipocytes and associated with several inflammatory responses 
(MacDougald and  Burant, 2007).  Additionally, eicosanoids are a class of hormones 
derived from essential fatty acids, predominantly arachidonic acid (C20:4n-6).  Three 
main types of eicosanoids, leukotrienes, thromboxanes, and prostaglandins, have also 
been associated with reproduction, inflammatory, and other immune-based physiologic 
processes.  An even newer concept in the role for adipocytes in whole body metabolism 
is that fatty acids, themselves, can act as cell signals.  Cao et al. (2008) identified a 
particular fatty acid, palmitoleic acid (C16:1 cis-9), present in low levels throughout 
bodily tissues that acts as a hormone to regulate lipogenesis and coined the term 
“lipokine”.  While a full understanding of the regulatory functions of adipocytes and their 
constituents has not been realized in the literature, data support adipose tissue to be a 
diverse endocrine organ that can affect whole body metabolism in addition to serving as 
an energy reservoir.  Many disease states are already associated with altered fatty acid 
metabolism including cardiovascular disease, type II diabetes, obesity, and some cancers.  
Less known are the regulatory functions of adipocytes that maintain homeostasis or 





FATTY ACIDS AND LIPOGENESIS 
Fatty acids are generally classified as saturated or unsaturated, based on the 
bonding pattern that occurs within the hydrocarbon skeleton of the fatty acid molecule.  
Fatty acids are composed of a carboxylic acid group attached to a hydrocarbon chain of 
varying length.  If each carbon in the chain has the maximum possible number of 
hydrogen atoms attached to it, or no double bonds, the fatty acid molecule is considered 
saturated.  Conversely, if there is at least one double bond between two carbon atoms in 
the hydrocarbon chain, the fatty acid is unsaturated.  A MUFA has only one double bond 
and a PUFA has two or more double bonds present within its hydrocarbon chain.  Most 
animal fats are high in SFA, whereas plant oils are mostly comprised of PUFA.  The two 
essential PUFA required by ruminants are linoleic acid (C18:2n-6), an omega-6 fatty 
acid, and linolenic acid (C18:3n-3), an omega-3 fatty acid.  With the exception of 
common names, fatty acid nomenclature uses the carbon length, double bond location, 
and geometric structure to designate specific fatty acids.  „Lipid numbers‟ is the most 
widely used naming system.  It uses a Cx:yz structure, where x is the number of carbons, 
y is the number of double bonds, and z lists the geometry and location of each double 
bond as cis- or trans-, counting from the carboxylic acid end.  For example, oleic acid 





 carbons.  With some PUFA, in lieu of listing all double bond locations 
and geometry, an omega designation is often used.  As the name implies, omega refers to 
the last carbon in the hydrocarbon chain, or the methyl carbon.  Counting back toward the 





instance, linolenic acid can be listed as C18:3 cis-9, cis-12, cis-15 or simply C18:3n-3 
because the double bond is on the third carbon away from the methyl end. 
Fatty acids stored in adipocytes can come from two sources: diet or de novo 
synthesis.  For most animals, dietary fatty acids are separated from their larger fat 
particles and lipid molecules in the lumen of the small intestine by bile salts and 
pancreatic lipase.  Fatty acids are absorbed into intestinal epithelium, reassembled into 
triglycerides, and passed into the bloodstream for transport to the liver before traveling to 
the rest of the body as components of lipoproteins.  The liver is a critical organ in the 
conversion of fatty acids into various forms which are used throughout the body.  Dietary 
fatty acids are then incorporated into body tissues and fluids where they can play a 
dynamic role in hormone synthesis.  Due to biohydrogenation of lipids in rumen of 
pregastric fermentors, energy metabolism has developed a little differently in these 
animals.  Ruminants have adapted over thousands of years to digest a wide variety of 
feedstuffs with the aid of a symbiotic relationship with microbial organisms in their gut.  
These microbes are capable of digesting structural carbohydrates that most mammals are 
incapable of utilizing.  However, due to the microbial rumen environment, most dietary 
nutrients are only available to the animal second-hand.  The primary energy substrate 
ruminants receive from the diet is not glucose, but volatile fatty acids (VFA), which are 
waste products of carbohydrate fermentation by microbes (Vernon, 1980; Smith and  
Crouse, 1984).  Lipids are another example of a microbially-modified nutrient, as dietary 





Unsaturated fatty acids are toxic to the rumen‟s microbial population, especially 
to those responsible for fiber digestion; therefore, the microbes have adapted the use of 
biohydrogenation to solve this problem.  Biohydrogenation sequentially removes double 
bonds and makes unsaturated fatty acids increasingly more saturated.  Biohydrogenation 
decreases, but does not eliminate, the amount of PUFA available to the animal.  In 
forage-based diets, PUFA are in the form of galactolipids.  This is a molecule that has 
two fatty acids attached to a glycerol backbone with a galactose bound to the third carbon 
(monogalactosyl diacylglycerol).  Additional galactose residues can be attached to the 
glycerol-bound galactose, increasing the fermentability of the galactolipid.  In grain-
based diets, triglycerides are the primary form of lipid.  A triglyceride is a molecule with 
three fatty acids bound to a glycerol backbone.  For these lipids to be absorbed, they are 
broken down into free fatty acids (FFA), galactose, and glycerol.  Microbes produce 
galactosidases which cleave galactoses from the glycerol molecule, resulting in free 
sugars and diacylglycerol.  Microbial lipases cleave the fatty acids from the glycerol.  
Also, microbes in the rumen have general esterases and extracellular lipase that result in 
the separation of triglycerides and diacylglycerides into FFA and glycerol.  Once the fatty 
acids are „free‟, they are susceptible to biohydrogenation.  There are several pathways for 
biohydrogenation, and research has not clearly elucidated all the possible routes of 
biohydrogenation.  The process by which double bonds are removed from the carbon 
backbone are PUFA specific and have evolved to use the least amount of energy based on 
the positioning of the bonds.  The primary end-product of C18:2n-6 and C18:3n-3 





Jenkins, 2011).  However, not all fatty acid molecules are fully saturated during the 
biohydrogenation process; PUFA and biohydrogenation intermediates escape the rumen 
and can be found in animal plasma, tissue, and milk.   
Microbes in the rumen ferment carbohydrates into VFA which are absorbed 
across the epithelial lining of the rumen, reticulum, and omasum.  There is no active 
transport of VFA; they travel by passive diffusion down the concentration gradient.  The 
rate of absorption, equal for all pregastric stomach compartments, is positively correlated 
with decreasing pH and increasing VFA chain length.  The three predominant VFA are 
acetate, propionate, and butyrate, and each has a distinct fate in metabolism.  A small 
amount of propionate, about 5%, is converted to lactate by the rumen epithelium and the 
majority is sent to the liver for gluconeogenesis.  Butyrate is extensively metabolized into 
ketone bodies in the rumen epithelium: acetoactetate, -hydroxybutyrate, or acetone.  
Approximately 5% of acetate is converted into ketone bodies by the rumen epithelial 
cells, but the majority of acetate is transported to the liver where it is converted to acetyl-
CoA.  Of this acetyl-CoA, 80% is circulated to the rest of the body while the remaining 
20% enters the citric acid cycle for ATP production.  In the peripheral tissues, acetyl-
CoA is predominantly used as a substrate for de novo fatty acid synthesis in adipose 
tissue (Figure 1).  Cattle have very little to no citrate lyase activity.  Therefore, they use 
very little glucose as a carbon source for fatty acid synthesis, but can utilize acetyl-CoA 
directly.  However, glucose contributes a relatively greater proportion of acetyl units to 
fatty acid biosynthesis in intramuscular adipose tissue compared with subcutaneous 





acid synthesis is white adipose tissue, as opposed to most nonruminants where the 
primary site of fatty acid synthesis is the liver.    
 Fatty acid synthesis begins with the committed step of adding a carboxyl group to 
acetyl-CoA, forming malonyl-CoA, by acetyl-CoA carboxylase (ACC).  Fatty acid 
synthase (FASN) is a large, multimeric protein that binds acetate and malonyl-CoA or 
another fatty acyl-CoA.  It uses NADPH in a series of sequential reactions to condense 
the substrates into a SFA product that is two carbons longer than the original malonyl- or 
fatty acyl-CoA.  The process is repeated until the fatty acid reaches a length of 16 
carbons, palmitoyl-CoA (Figure 1).  Short and medium chain fatty acids can enter this 
process at any step.  As FASN is not able to elongate fatty acids greater than 16C, a 
family of elongase enzymes (ELOVL) is responsible for elongating fatty acids after this 
point (Figure 1).  Stearoyl-CoA desaturase (SCD) is a 
9
 desaturase that it inserts a cis-
double bond between carbons 9 and 10 on the hydrocarbon chain, counting from the 




 desaturase; therefore, 
dietary plant material is the primary source C18:2 n-6 and C18:3 n-3.  Arachidonic acid 
(C20:4 n-6) is also considered an essential fatty acid in most mammalian species due to a 
reduced capacity or inability to synthesize it from C18:2 n-6 in sufficient quantities to 
meet the demands of the body.  These pathways in combination with dietary fatty acids 
subjected to biohydrogenation result in a variety of fatty acid products.  In order from 
greatest to least, the major fatty acids present in beef are C18:1 cis-9, palmitic acid 
(C16:0), C18:0, and C18:2 n-6 (Duckett et al., 1993).  The order of predominance 





based diet to:  C18:1 cis-9, C16:0, C18:0, C16:1, and C18:2 n-6 (Pavan and  Duckett, 
2008).  Other fatty acids of importance to human health that are present in beef are 
conjugated linoleic acids (CLA) and omega-3 fatty acids (Table 1).  Once synthesized or 
processed in adipocytes, free fatty acids can be packaged into triglycerides for storage, 
sphingolipids and phospholipids for membrane components, cholesterols and eicosanoids 
for hormone production.  In addition, fatty acids can undergo -oxidation to provide ATP 






Adipogenesis is defined as the differentiation of preadipocytes into functional 
adipocytes.  Cellular changes due to adipogenesis are characterized by cell morphology 
change, gene and protein expression, and function of the cell.  Differentiation is initiated 
through extracellular signals altering gene expression at the transcriptional and translation 
level.  The full developmental origins of preadipose tissue from a single cell are 
unknown, but are thought to have mesodermal origins (Ntambi and  Kim, 2000; 
Cornelius et al., 1994).  In humans, preadipocytes begin to differentiate into adipose 
tissue during late embryonic development and majority of differentiation occurring 
shortly after birth (Burdi et al., 1985).  In mice and rats, preadipocytes do not begin to 
differentiate until after birth (Ailhaud et al., 1992).  Early-onset obesity in humans is a 
result of both hyperplasia and hypertrophy of adipose tissue, but adult-onset obesity is 
primarily a result of adipocyte hypertrophy (Hirsch and  Batchelor, 1976).  However, 
morbidly obese humans, those greater than 170% of ideal body fat, display both 
hyperplasia and hypertrophy of adipocytes (Hirsch and  Batchelor, 1976).  Fat deposition 
in finishing cattle is resultant from a combination hyperplasia and hypertrophy; 70% of 
which is due to the latter (Robelin et al., 1985).   
Most of the work characterizing adipogenesis has been conducted using murine in 
vivo and in vitro models.  In cell culture models, a hormone cocktail is commonly used to 
initiate differentiation, although fatty acids or sheer confluence of the cells can also 
induce a level of differentiation (Ntambi and Kim, 2000).  In vivo, the process is less 





excess energy, differentiation of cells increases to meet the storage demands (Ntambi and  
Kim, 2000).  The changes in gene transcription that ultimately lead to altered cell 
function as mature adipocytes are initiated by transcription factors (Figure 2).  Some of 
the first transcription factors to increase at the onset of differentiation are 
CCAAT/enhancer binding proteins (C/EBP)- and .  The C/EBP-  isoform is 
thought to be mediated by C/EBP-  and –  (Ntambi and  Kim, 2000).  These C/EBP 
increase within 1 h and dissipate within 24 h in differentiating cells (Cornelius et al., 
1994).  Next, peroxisome proliferator-activated receptor (PPAR)-  and –  increase and 
are also thought to be mediated by C/EBP-  and –  (Clarke et al., 1997).  Based on 
mouse research, the master regulator of adipocyte regulation is classically stated as 
PPAR .  It homodimerizes or heterodimerizes with retinoid X receptor or retinoic acid 
receptor to promote transcription of lipogenic genes (Rosen et al., 2000).  Adipocyte 
protein 2 [aP2, also known as fatty acid binding protein 4 (FABP4)], sterol regulatory 
element binding protein (SREBP), and SCD mRNA expression increase around day 2 to 
4 after initial differentiation (Amri et al., 1991).  Sterol regulatory element binding 
protein is proteolytically matured by SREBP-cleavage activating protein which senses 
falling sterol levels within the cell and transports SREBP from the membrane of the 
endoplasmic reticulum to the Golgi complex.  In the Golgi membrane, site 1 protease and 
site 2 protease sequentially cleave SREBP into its mature form, n-SREBP, which is 
transported to the nucleus of the cell.  There, it binds to the sterol response element of 
lipogenic genes.  The three known isoforms of SREBP are -1a, -1c, and -2.  All SREBP-





activate fatty acid and cholesterol synthesis genes, respectively (Brown and  Goldstein, 
1997; Horton et al., 2002; Eberlé et al., 2004).     
Stearoyl-CoA desaturase could be used as an indicator of differentiation timing in 
vivo (Martin et al., 1999).  Growing cattle, 5 to 12 mo of age, showed increased SCD 
gene expression in subcutaneous adipose tissue that peaked at 12 mo of age (Martin et al., 
1999).  Following this peak, cellularity of the adipose tissue changed with increased lipid 
filling.  As stated earlier, cattle finished on high concentrate diets have altered fatty acid 
profiles and lipid deposition rates compared to pasture-finished animals (Pavan and  
Duckett, 2008).   Therefore, diets of finishing cattle could be used to impact adipose 
tissue at the level of differentiating cells, lipid-filling adipocytes, or both.  In addition to 
diet and depot having an effect on adipogenesis in vivo, the depot of fat that 
preadipocytes are cultured from can have a profound effect on their performance in vitro.  
For instance, Grant et al. (2008a) reported that cells isolated from subcutaneous fat had 
6.4-fold greater percentage of differentiated cells within individual colonies than cells 
isolated from intramuscular fat.  In addition, cultures derived from subcutaneous fat had 
greater response to differentiation media than cultures from omental adipose tissue (Wu 
et al., 2000).  Wu et al. (2000) found that cells from different tissues responded to 
exogenous hormones differently with the greatest degree of hormonally-induced 
differentiation in subcutaneous fat.    However, Grant and others saw no differential 
effects of troglitazone (TRO) on the differentiation of subcutaneous or intramuscular 





A majority of research on the regulation of adipogenesis has been conducted with 
murine models and in vitro studies using the immortalized 3T3-L1 cell line derived from 
disaggregated Swiss 3T3 mouse embryos (Green and  Kehinde, 1974), although, some 
research has gone into creating and characterizing primary and clonally-derived bovine 
preadipocyte cell lines (Grant et al., 2008a and b; Taniguchi et al., 2008a and b).  Classic 
hormones used to differentiate cells in vitro are isobutylmethylxanthine (IBMX), insulin, 
TRO, and dexamethasone (DEX).  The first hormone listed, IBMX, is a 
phosphodiesterase inhibitor which increases cAMP and protein kinase A, which are part 
of an intracellular signaling cascade that ultimately lead to increased transcription factor 
activity including C/EBP- (Ntambi and  Kim, 2000).  Insulin acts through the insulin-
like growth factor-1 receptor, which is a tyrosine kinase receptor, to stimulate 
transcription factor activity.  Members of the thiazolindedione drug class, such as TRO, 
function as a PPAR  agonists (Kim et al., 2000; Grant et al., 2008b).  Dexamethasone is a 
synthetic glucocorticoid that binds to a glucocorticoid receptor in the nucleus of the cell, 
or in cytosol of the cell and translocates to the nucleus (Ntambi and  Kim, 2000).  Once in 
the nucleus, the glucocorticoid-receptor complex homodimerizes and binds to the 
glucocorticoid response element on the DNA strand.   
There are 2 general methods for isolating stromal-vascular (SV) cultures from 
bovine adipose tissue:  enzymatic digestion and tissue explants.  Each method has its own 
positives and negatives.  For instance, enzyme digestion yields faster establishment of 
cultures, but tissue explants require less starting material and result in „cleaner‟ cultures 





method of culture isolation where adipocytes, not preadipocytes, are specifically targeted.  
The basis of this approach is founded on the potential for adipocytes to „de-differentiate‟, 
where mature, lipid-filled adipocytes revert back to a propogative state.  The concept of 
de-differentiation disputes the idea that once cells accumulate lipid for storage, they are 
terminally differentiated.  Aso et al. (1995) developed clonal preadipocyte cell lines with 
recombinant bovine fibroblast growth factor and differentiated cells with glucose, insulin, 
DEX, and acetate.  Regardless of the isolation method, several laboratories have 
published papers pertaining to the gene expression and differentiation of bovine 
adipocytes in vitro.  Grant et al. (2008a) demonstrated that bovine preadipocytes were 
capable of differentiating in response to combinations of insulin, serum lipids, DEX, and 
TRO.  They also titrated an optimum level of TRO supplementation in vitro to induce 
differentiation in bovine primary SV cultures (2008b).  Data used to support the 
occurrence of differentiation included Oil Red O staining of lipid in cells and increased 
glycerol-3-phosphate dehydrogenase (GPDH) protein and activity.  Hirai et al. (2007) 
also reported on SV-culture isolation via collagenase digestion and differentiation of 
cultures.  Using insulin, IBMX, TRO, and DEX, they reported successful differentiation 
of cultures evidenced by Oil Red O staining, GPDH activity, Northern blot of aP2 mRNA 
expression, and semi-quantitative PCR of C/EBP- ,-  and PPAR mRNA.   In another 
study, insulin, IBMX, and DEX were used to initiate differentiation and followed by the 
addition of intralipid or lipoproteins, which enhanced differentiation in cultures (Wu et 
al., 2000).   Lengi and Corl (2010), who use the tissue explant method of SV isolation, 





differentiation.  The objective measures of differentiation used were radiolabeled acetate 
incorporation (1,2-
14
C2) into cellular lipids, GPDH activity, and mRNA expression of 
aP2, PPAR , and ACC (Lengi and  Corl, 2010).  All media combinations tested positive 
for at least parameter of differentiation compared with the no hormone-added controls.  
Expression of aP2 and PPAR  mRNA was elevated with the Aso et al. (1995) and Wu et 
al. (2000) media; whereas, ACC mRNA expression and acetate incorporation were 
elevated with the Wu et al. (2000) and Hirai et al. (2007) media.  Addition of TRO or 
roglitazone, another member of the thiazolidinediones drug class, to the Wu et al. (2000) 
media further enhanced differentiation in all parameters tested (Lengi and  Corl, 2010).  
Despite the amount of literature on differentiation and gene expression, no fatty acid 
composition data has been reported in bovine adipocyte cultures to date.   As lipogenic 
genes are activated during the course of differentiation, the fatty acid composition may be 





FATTY ACID REGULATION  
 Regulation of de novo fatty acid synthesis can occur at many different levels:  
transcription of mRNA, translation of message into protein, and activity of the protein.  
Each enzyme in the lipogenesis pathway can be regulated (Table 2), in addition to 
cellularity of adipose tissue.  The first enzyme in fatty acid synthesis acetyl-CoA 
carboxylase (ACC) is regulated allosterically and by phosphorylation.  Citrate activates 
ACC by changing its conformation to a multimeric, filamentous complex, and palmitoyl-
CoA inactivates ACC by promoting a monomeric, or protomer, form.  Insulin-activated 
protein phosphotase activates ACC by dephosphorylation, and AMP-activated kinase 
inactivates it by phosphorylation.  Regulation of ACC can also occur at the level of 
transcription, but is not the primary mechanism.  The next enzyme responsible for de 
novo fatty acid synthesis, FASN, is transcriptionally regulated.  Insulin stimulates its 
expression by mediating upstream regulatory factors and SREBP (Eberlé et al., 2004).  
Leptin diminishes its expression inhibiting SREBP and directly blocking FASN 
transcription.  Regulation of SCD is predominantly at the transcription level; although, it 
can be directly inhibited by sterculic acid, a cyclopropenoid fatty acid (Gomez et al., 
2003).  Expression of SCD is sensitive to many dietary factors, hormones, and SREBP-1c 
activity (Tabor et al., 1999; Ntambi and  Miyazaki, 2004).  The elongase proteins are also 
thought to be regulated at the transcription level (Matsuzaka et al., 2002).  Transcription 
factors that regulate ELOVL6 include SREBP and PPAR ; ELOVL5 expression is up-





ELOVL6 is also being investigated using a synthetic, chemical inhibitor (Shimamura et 
al., 2009; Shimamura et al., 2010).   
Stearoyl-CoA desaturase is the rate-limiting enzyme in the production of MUFA 
from SFA.  It is one of several markers for differentiation of preadipocytes into mature 
adipocytes, along with aP2 and PPAR  (Chawla et al., 1994; Ohsaki et al., 2007).  
Stearoyl-CoA desaturase is called a 
9





 carbons in the hydrocarbon skeleton, counting from the carboxyl 
end (Ntambi, 1999).  The preferred substrates for SCD are palmitoyl- and stearoyl-CoA, 
which become palmitoleoyl- and oleoyl-CoA, respectively.  Also, SCD can convert 
trans-vaccenic acid (C18:1 trans-11), a biohydrogenation intermediate, to CLA cis-9, 
trans-11, a potent anticarcinogen (Parodi, 1997).  Because of its role in biosynthesis of 
MUFA, SCD can impact membrane fluidity and composition of stored triglycerides by 
changing the ratio of SFA: MUFA.  While transcription of SCD mRNA is thought to be 
controlled primarily by SREBP that binds to sterol response element in the promoter 
region of the SCD gene, it is also regulated by many other factors (Eberle et al., 2004; 
Lay et al., 2002).  As reviewed by Ntambi and Miyazaki (2004), glucose, cholesterol, 
vitamins A and D, insulin, and estrogen increase SCD expression, but PUFA, leptin, 
glucagon, and thiazolidinediones decrease it.  In addition to PUFA‟s control over SCD 
expression, SCD is regulated in part by its products and not by the availability of its 
substrates (Keating et al., 2006).  For instance, the addition of CLA cis-9, trans-11 
reduces expression of SCD mRNA, but increasing amounts of C18:1 trans-11 does not.  





response element, and SREBP-response region (Keating et al., 2006).  Decreased SCD 
expression seen in murine and mammary cells treated with C20:4 n-6 and CLA trans-10, 
cis-12 may be a result of altered promoter binding at the PUFA response element of the 
SCD gene.   
 The majority of research focused on SCD has used the rodent model or the 
immortalized cell line 3T3-L1.  However, in contrast to the localized, hepatic-expression 
of murine SCD, bovine SCD is expressed throughout the body in adipose tissue of 
growing animals and also in the mammary gland of lactating animals (Martin et al., 1999; 
St John et al., 1991).  Four isoforms of SCD have been identified in mice and, thus far, 
only two isoforms have been identified for SCD in ruminant species (Lengi and Corl, 
2007; Ward et al., 1998).  The SCD1 isoforms in cattle, goats, and sheep are homologs 
and similar to murine SCD1;  the SCD5 isoform, once thought to be unique to primates, 
is expressed in the brain and pancreas of humans and cattle (Lengi and Corl, 2007; Wang 
et al., 2005).  Despite inherent differences in ruminant adipose tissue metabolism that 
exist compared to monogastric animals, in terms of glucose uptake and de novo synthesis 
of fatty acids from acetate (Aso et al., 1995), they are similar with respect to location of 
SCD isoform expression.   
There is also a relationship between SCD expression and obesity.  High levels of 
SCD are seen in obese human patients, as well as the insulin-resistant, obese Zucker rats 
(Hulver et al., 2005; Voss et al., 2005).  It remains to be determined if elevated SCD is 
the causal agent in adiposity or if increased SCD is simply a product of greater 





over-expression may lead to valuable insights into the role of SCD in vivo, especially in 
regards to tumor development, obesity, and type II diabetes.  Stearoyl-CoA desaturase 
over-expression has been associated with increasing MUFA, decreasing SFA, and 
subsequent weakening of cellular membranes (Sun et al., 2003).  With increasing 
amounts of SCD, the primary products of its enzymatic reaction, C18:1 cis-9 and C16:1, 
increase, provided that substrates are available.  Increasing ratios of C18:1 cis-9/C18:0 
are associated with certain types of tumors, thus implicating SCD in carcinogenesis 
(Khoo et al., 1991).  In particular, high levels of SCD have also been related to several 
conditions that are directly linked with hepatocarcinogenesis in humans, including 
hepatosteatosis (Falvella et al., 2002). Research involving over-expression of SCD in 
adipocytes is limited, due in part to the difficulties associated with transfecting fat cells.  
Gene knock-down and silencing techniques have been used most often to investigate the 
role of SCD.   
Prime animal models for the study of SCD are the SCD1-deficient asebia mice 
and SCD1-knockout mice.  Some of the effects of SCD knockdown in mice are visually 
evident.  Mice with targeted disruption of the SCD1 gene are leaner than their wildtype 
counterparts and resistant to diet-induced adiposity (Ntambi et al, 2002).  Whole gene 
deletions of SCD1 in mice also result in a lean phenotype, but have poor hair coat and dry 
eyelids due to atretic sebaceous and meiobium glands thought to be caused by increased 
circulation of free cholesterols previously associated with cell death (Ntambi and 
Miyazaki, 2004).  Other non-visible characteristics of SCD1 depression are increased 





et al., 2003; Ntambi et al., 2002).  Differentiation of non-ruminant preadipocytes 
increases insulin-stimulated glucose uptake by GLUT4 (Kaestner et al., 1989).  In mice, 
SCD knockout increases the levels of GLUT4 in the cellular membranes (Rahman et al., 
2003).  However, in bovine preadipocytes and adipocytes, Aso et al. (1995) reported that 
GLUT4 was not active.  To date, SCD1 or SCD5 knockdown has not been performed on 
bovine adipocytes.  If SCD is absent, biosynthesis of MUFA from SFA cannot proceed, 
and SFA will accumulate in the cell, potentially causing cell death due to lipotoxicity.  
Lipotoxicity, an event that triggers apoptosis, has been associated with high levels of 
SFA and can be attenuated by supplementation with unsaturated fatty acids (Hardy et al., 
2000; Listenberger et al., 2003).  In murine hepatocytes, C16:0 induced apoptosis, but 
C18:1 cis-9 rescued cells from C16:0-induced apoptosis and promoted lipid filling in 
hepatocytes (Li et al., 2009).    
Similar to results seen with SCD1-deficient mice, aP2-deficient mice also show 
protection against diet-induced obesity, reduced hepatosteatosis, and improved insulin 
sensitivity (Hotamisligil et al., 1996; Newberry et al., 2006).   These are interesting 
systemic effects as expression of this lipid chaperone, as well as SCD1 expression, is 
very tissue specific.  In addition, there seems to be depot-specific regulation of lipogenic 
genes as mRNA expression of ACC, FASN, SCD1, and ELOVL6 were all down-
regulated in liver and up-regulated in the epididymal fat pad of aP2-knockout mice (Cao 
et al., 2008).  Analysis of lipid profiles in these tissues revealed palmitoleic acid (C16:1 
cis-9), a product of the SCD1 reaction, was significantly elevated in aP2-knockout 





phospholipids, and cholesterol esters (Cao et al., 2008).   When plasma lipids from aP2-
knockout mice were used to incubate adipose tissue explants, Cao et al. (2008) reported a 
decrease in inflammatory properties.  Furthermore, murine adipocytes incubated with 
palmitoleic acid showed a reduction in cytokine expression compared with adipocytes 
incubated with palmitic acid (C16:0).  Murine SV cultures did not show differences due 
to fatty acid treatment suggesting palmitoleic acid affects functional adipocytes only (Cao 
et al., 2008).  These results led to the hypothesis that dysfunction of lipid metabolism 
seen in disease states associated with obesity could be attenuated by exogenous 
palmitoleic acid administration; that palmitoleic acid could act as a hormone signal to the 
rest of the body.  To summarize the results of Cao et al. (2008) produced by several 
different methodologies, palmitoleic acid decreased hepatic SCD1 mRNA and protein 
expression, decreased FASN and ELOVL6 mRNA expression, and increased skeletal 
muscle insulin sensitivity and glucose disappearance from plasma.  Based on this data, 
Cao et al. (2008) suggested palmitoleic acid may function as a hormone and coined the 
term „lipokine‟.  However, the mode of regulation is remains unclear. Scrambling the 
sterol response element in the promoter region of the SCD gene removed palmitoleic 
acid‟s inhibitory effect on SCD mRNA expression (Cao et al., 2008).  Therefore, the 
mechanism through which palmitoleic acid could be acting is SREBP-1c.  As stated 
previously, SREBP binds to the sterol response element of several lipogenic genes to 
affect their transcription.  In addition, palmitoleic acid could be acting more directly on 
lipogenic genes at the protein level.  The half-life of SCD1 is known to be relatively 





supplementation increased SCD1 degradation in hepatocytes; whereas, palmitic acid 
stabilized it (Cao et al., 2008).   
Overall, the lipokine hypothesis highlights a potential regulatory pathway in 
which palmitoleic acid functions as an indicator of energy status in the body.  Palmitoleic 
acid is usually present at low levels throughout bodily tissues and is primarily produced 
by de novo fatty acid synthesis, as there are very few dietary sources high in palmitoleic 
acid.  Acetyl-CoA carboxylase and FASN are responsible for assimilating malonyl-CoA 
and fatty acyl-CoA into C16:0 and C18:0 fatty acids from acetate or glucose precursors.  
Both C16:0 and C18:0 can be desaturated by SCD into C16:1 cis-9 and C18:1 cis-9, 
respectively.  A build-up of palmitoleic acid would suggest to the body that energy 
sources are abundant, fatty acid synthesis and desaturation are proceeding too rapidly, 
and resources should be partitioned away from lipogenesis, perhaps toward 
gluconeogenesis, glycogen synthesis, or -oxidation.  In humans, high plasma 
concentrations of palmitoleic acid are associated with elevated serum triglycerides, 
abdominal adiposity, and overall obesity (Attie et al., 2002).  Additionally, an 
observational study by Gong et al. (2010) reported a positive association between 
palmitoleic acid in adipose tissue and obesity.  A low carbohydrate diet reduced this 
correlation (Gong et al., 2010).  It is possible that fatty acid composition in the diet, 
plasma, liver, and adipose tissue depots may all contribute to regulating lipid and 
carbohydrate homeostasis.  Research in this area is limited due to inherent complexities 
of controlling for diverse physiologic and pathological conditions which can impact lipid 





tissue and glucose metabolism in skeletal muscle improved with the strategic use of 
palmitoleic acid, it might serve as therapy for obesity and type II diabetes in humans, as 






Table 1.  Predominant fatty acids in ruminant tissues:  Nomenclature, primary sources, and implications for human health. 
Common Name Lipid Numbers IUPAC Name Primary Source in Ruminants
1
Implications for Human Health
Palmitic acid C16:0 hexadecanoic acid de novo synthesis raises serum LDL
2
Palmitoleic acid C16:1 cis- 9 (Z)-9-hexadecenoic acid desaturated from C16:0 associated with obesity and insulin
3
Stearic acid C18:0 octadecanoic acid biohydrogenation lower serum LDL
4
Oleic acid C18:1 cis- 9 (Z)-9-octadecenoic acid desaturated from C18:0 lower LDL and blood pressure
5
Cis -Vaccenic acid C18:1 cis- 11 (Z)-11-octadecenoic acid biohydrogenation, elongated from C16:1 lower total cholesterol and TG
6
[Trans -] Vaccenic acid C18:1 trans- 11 (E)-11-octadecenoic acid biohydrogenation precursor of CLA cis- 9, trans- 11
Linoleic acid C18:2 n-6 (Z,Z)-9,12-octadecadienoic acid dietary by-pass essential fatty acid
7
Conjugated linoleic acid (CLA) C18:2 trans- 10, cis- 12 (E,Z)-10,12-octadecadienoic acid biohydrogenation potential anti-obesity
8
Rumenic acid (or CLA) C18:2 cis- 9,  trans- 11 (Z,E)-9,11-octadecadienoic acid biohydrogenation, desaturated from C18:1 trans- 11 potential anti-carcinogenic
9
[ -]Linolenic acid C18:3 n-3 (Z,Z,Z)-9,12,15-octadecatrienoic acid dietary by-pass essential, anti-inflammatory
7
Arachidonic acid C20:4 n-6 (Z,Z,Z,Z)-5,8,11,14-eicosatetraenoic acid dietary by-pass, synthesis from C18:2n-6 essential, inflammatory mediator
7
1
Primary source of endogenous fatty acids found in ruminant tissues. 
2
Hegsted et al., 1965
3
Cao et al., 2008; Gong et al., 2010; Stefan et al., 2010
4
Denke and Grundy, 1985
5
Mattson and Grundy, 1985
6
Uchiyama et al., 1966
7
Burr et al., 1932
8
Park et al., 1999
9








Table 2.  Lipogenic gene function and regulation.   
 
Gene Name Function Mode of Regulation Known Inhibitors (Activators)
Acetyl-CoA Carboxylase (ACC) first step of de novo  lipogenesis allosteric inhibition C16:0 (Citrate)
phosphorylation AMP-activated kinase (Insulin-activated protein phosphotase)
transcription
Fatty acid synthase (FASN) de novo  lipogenesis up to 16C transcription Leptin (Insulin, SREBP-1c)
Stearoyl-CoA desaturase 1 (SCD1) inserts double bond at 
9
 position transcription PUFA (Insulin, SREBP-1c)
allosteric inhibition Sterculic acid
Fatty acid elongase 5 (ELOVL5) adds 2C to fatty acids C in length transcription (Peroxisome proliferator-activated receptor  (PPAR ))
Fatty acid elongase 6 (ELOVL6) adds 2C to fatty acids 16-18C in length transcription (SREBP-1c, PPAR )
allosteric inhibition synthetic drug
Sterol regulatory element lipogenic gene transcription factor proteolytic maturation
         binding protein (SREBP-1c)








Figure 1.  An overview of fatty acid synthesis in the ruminant adipocyte.  Lipids 
packaged in lipoproteins are transported to adipocytes where lipoprotein lipase (LPL) 
releases free fatty acids, which can diffuse through the cell membrane.  Free fatty acids 
can undergo fatty acid synthesis reactions such as desaturation by stearoyl-CoA 
desaturase 1 (SCD1).  Volatile fatty acids (VFA) can freely diffuse across the cell 
membrane and undergo de novo fatty acid synthesis.  Acetyl-CoA carboxlyase (ACC) is 
the committed step, followed by sequential fatty acid synthase (FASN) reactions which 
elongate fatty acyl-CoA to 16C in length.  Bound to the endoplasmic reticulum 
membrane, elongase protein 6 (ELOVL6) can further elongate fatty acyl-CoA and SCD1 
can add a double bond at the 
9
 position.  Fatty acids can be packaged for use or storage 
into other lipid products or undergo -oxidation in the mitochondria for energy 
production.  Sterol regulatory element binding protein-1c (SREBP) is a transcription 
factor for many lipogenic genes.  Other proteins, sensing intracellular signals, carry 
SREBP to the golgi apparatus where it is proteolytically matured.  Once in the active 
form, SREBP travels to the nucleus where it serves as a transcription factor, binding to 






Figure 2.  Chronological progression of major gene expression changes in differentiation 
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CHAPTER 2:  GENE EXPRESSION AND FATTY ACID 
PROFILES DURING DIFFERENTIATION OF BOVINE 
ADIPOCYTE CULTURES SUPPLEMENTED WITH 
LINOLEIC ACID (C18:2 n-6) 
 
ABSTRACT 
The primary objectives of this study were to determine if fatty acid profiles or 
lipogenic gene expression differ when in vitro adipocytes are exposed to supplemented 
linoleic acid (C18:2 n-6), insulin, or both following differentiation.  With limited 
information in the literature about the timing of lipid uptake and composition of fatty 
acids in differentiating bovine adipocytes, a secondary objective of this study was to 
evaluate fatty acid composition over time.  Primary stromal vascular cultures were 
isolated from 18 mo. old Angus crossbred steers by collagenase digestion.  In the first 
experiment, cells were hormonally induced to differentiate on d 0, cultured to d 12, serum 
starved for 24 h, and assigned to 1 of 4 treatments in a 2 X 2 factorial design consisting of 
linoleic acid (0 mM or 0.3 mM C18:2 n-6) and insulin (0 or 2.5 g/mL) as factors.  Cells 
were harvested on d 18, following 5 d of incubation with respective treatments, for fatty 
acid analysis and gene expression.  In a second experiment, cells were assigned to 
treatments according to a 2 X 3 factorial design consisting of linoleic acid (0 or 0.3 mM 
C18:2 n-6; beginning on d 2) and day of harvest (d 2, 6, or 12) as factors.   
Undifferentiated cells harvested on d 2 served as baseline controls.  As before, cells were 
harvested for fatty acid and gene expression analysis.  In the first experiment, total fatty 




(C18:1 cis-9), and linolenic (C18:3 n-3) acids decreased (P < 0.05) due to a main effect 
of linoleic acid supplementation.  Desaturation indices and SCD1 mRNA expression also 
decreased (P < 0.05) in response to linoleic acid supplementation.  Insulin treated cells 
also had decreased (P < 0.05) C18:1 cis-9/C18:0 desaturation ratio compared with 0 
g/mL treated cells and tended (P = 0.08) increased C18:2 n-6.  In the second 
experiment, there was interaction (P < 0.05) of linoleic acid supplementation and day of 
harvest for major fatty acids and desaturation indices.  With the exeption of C16:0, 
individual fatty acids and the ratio of C18:1 cis-9/C18:0 increased over time in 
unsupplemented cells and decreased or remained unchanged on d 6 and 12 in linoleic 
acid-treated cells.  Regardless of linoleic acid supplementation level, analysis of mRNA 
expression revealed that fatty acid synthase (FASN), glucose transporter 4 (GLUT4), and 
peroxisome proliferator-activated receptor gamma (PPAR ) mRNA expression was 
elevated (P < 0.05) in differentiated cells on d 12 compared with undifferentiated cells.  
Messenger RNA of stearoyl-CoA desaturase 1 (SCD1) and adipocyte protein 2 (aP2), 
differentiation-associated genes, was up-relgulated (P < 0.05) in differentiated cells on d 
2 compared with undifferentiated cells and down-regulated (P < 0.05) on d 6 and 12 
compared with d 2.  A significant interaction existed between time and treatment for 
sterol regulatory element binding protein-1c (SREBP).  Unsupplemented cultures were 
decreased (P < 0.05) in their expression of SREBP mRNA on d 6 and 12 compared with 
undifferentiated cells; whereas, linoleic acid-treated cells increased (P < 0.05) over time.  
In conclusion, fatty acid composition changes with respect to time following induction of 




culture media with linoleic acid reduced SCD1 transcription at d 18 and decreased 
desaturation indices at d 6, 12, and 18.  Bovine adipocyte cultures were actively 
desaturating fatty acids, which led to changes in fatty acid composition of the cultures.  In 
addition, by d 6 cultures were sensitive to lipogenic regulation by exogenous fatty acid 
administration.  Based on our data of fatty acid uptake and mRNA expression changes of 
differentiation-associated genes, we propose to time future investigations of bovine 
adipocytes more closely with differentiation, from d 6 to 12, when cells are fully 





In the beef industry, USDA grading standards estimate cutability and eating 
quality of the lean tissue to determine carcass value.  These yield and quality grades 
applied to beef carcasses are highly influenced by the abundance of subcutaneous and 
intramuscular fat, respectively.  During the finishing stage in cattle, fat deposition in the 
form of white adipose tissue is the result of both hyperplasia and hypertrophy (Hood and  
Allen, 1973).  Although cell number and size both increase during animal maturation, 
70% of fat accumulation is the result of hypertrophy (Robelin et al., 1985).  
Preadipocytes, cells responsible for hyperplasia, are of mesenchymal lineage and have 
the ability to propagate or commit to differentiation (Gesta et al., 2007).  Upon 
stimulation, they differentiate into mature adipocytes, which have the ability to 
synthesize, take up, and store fat.  The composition and quantity of white adipose tissue 
is influenced by animal nutrition.  Cattle finished on high concentrate diets have altered 
fatty acid profiles and lipid deposition rates compared to pasture-finished animals (Pavan 
and  Duckett, 2008).   Therefore, diets of finishing cattle can potentially impact carcass 
value by altering adipose tissue at the level of differentiating preadipocytes, lipid-filling 
adipocytes, or both.  
Over the past decade, researchers have begun to view white adipose tissue, not as 
an inert energy storage site, but as a complex, metabolically active tissue (McGillis, 
2005). Obesity is associated with many common medical disorders including 
cardiovascular disease and type II diabetes.  The amount and location of white adipose 




consumers are increasingly concerned about saturated fatty acids (SFA) in beef.  By 
defining mechanisms through which adipogensis and lipogenesis are controlled, we can 
improve the nutritive quality of beef and potentially develop models to enhance our 
understanding individual health and obesity-onset in humans.   
A majority of research in fatty acid metabolism and adipogenesis has been 
conducted with murine models and in vitro studies using the immortalized 3T3-L1 cell 
line derived from disaggregated Swiss 3T3 mouse embryos (Green and  Kehinde, 1974), 
although some research has gone into creating and characterizing primary and clonally-
derived bovine preadipocyte cell lines (Grant et al., 2008a and b; Taniguchi et al., 2008a 
and b; Lengi and  Corl, 2010).  Gene expression during preadipocyte differentiation has 
been well documented in 3T3-L1 cells (Ntambi and  Kim, 2000).  To date, information 
regarding early events in bovine preadipocyte differentiation is primarily limited to gene 
expression.  Inherent differences in site of lipogenesis and substrate utilization in murine 
versus ruminant species necessitate investigation in this area.  Our objective in this study 
was to evaluate the fatty acid profiles and the expression of genes involved in 
differentiation and lipogenesis in bovine preadipocytes.  Fat is often added to livestock 
diets as energy supplements and in vitro cultures are sometimes used to investigate in 
vivo effects.  Linoleic acid (C18:2 n-6) is an essential fatty acid and is the predominate 
fatty acid found in most livestock feedstuffs and commonly used fat supplements, such as 
corn oil.  Duckett et al. (2009) reported up-regulated stearoyl-CoA desaturase 1 (SCD1) 
mRNA expression in adipose tissue of steers fed a corn-based supplement.  Insulin is 




and  Ntambi, 2009).  We hypothesized that supplementing bovine adipocytes cultures 
with linoleic acid, insulin, or both would impact gene expression and fatty acid 




MATERIALS AND METHODS 
Cell Culture.  Primary bovine stromal vascular (SV) cultures were harvested from 
subcutaneous flank fat of 18 mo old Angus crossbred steers according to Hirai et al. 
(2007).  At slaughter, ~30 cm
3
 sections of adipose tissue were excised and minced using 
sterile instruments, rinsed with Hank‟s Balanced Salt Solution (HBSS), and digested in 
25 mL HBSS containing 2 mg/mL collagenase, type I, and 40 mg/mL bovine serum 
albumin under constant shaking at 37°C for 120 min.  Remaining tissue fragments and 
fat-filled adipocytes were separated from the stromal vascular fraction by filtering 
through a 250 m nylon mesh and subsequent centrifugation at 2000 x g for 10 min.  




 and passaged every 2 to 4 d when approximately 
60% confluent.  Cells were incubated at 37°C under 5% CO2 humidified atmosphere with 
media [Dulbecco‟s modified eagles medium (DMEM) containing 10% fetal calf serum 
(FCS), and 2X antibiotiotic/antimycotic (AB/AM; containing 10,000 U/mL penicillin G, 
10,000 g/mL streptomycin, and 25 g/mL amphotericin B)] replaced every 2 d.  After 4 
passages, cell cultures were harvested and stored in liquid nitrogen at 1 x 10
6
 cells/mL in 
freeze media (DMEM, 20% FCS, and 10% dimethyl sulfoxide) for later use.   
Experiment 1.  Individual SV cultures from 3 steers were used in this study.  




.  Cells 
were allowed to reach confluence, held for 2 d, and differentiated on d 0 according to 
Hirai et al. (2007) with DMEM containing 5% FCS, 2X AB/AM, insulin at 2.5 g/ml, 0.5 
mM 2-isobutyl-1-methylaxanthine (IBMX), 0.25 M dexamethasone (DEX), and 5 M 




insulin at 2.5 g/mL, 5 M TRO) was applied, beginning on d 2 to d 12.  On d 12, the 
secondary differentiation media was replaced by a starvation media (DMEM, 0.1% BSA, 
2x Ab/Am) for 24 h.  Treatments, performed in duplicate for each culture, were applied 
in a 2 X 2 Factorial design with bovine insulin (0 g/mL or 2.5 g/mL; Sigma-Aldrich, 
St. Louis, MO) and linoleic acid (0 mM or 0.3 mM C18:2 n-6; BD Biosciences, Bedford, 
MA) as supplements in culture media.   Cells were harvested on d 18 for fatty acid and 
gene expression analysis by washing 3 times with PBS followed by trypsin digestion. 
Experiment 2.  Individual cultures from 2 steers were passaged and plated as 
described above.  Cells were allowed to reach confluence, held for 2 d, and differentiated 
on d 0 as described by Hirai et al. (2007) DMEM containing 5% FCS, 2X AB/AM, 
insulin at 2.5 g/ml, 0.5 mM 2-isobutyl-1-methylaxanthine (IBMX), 0.25 M 
dexamethasone (DEX), and 5 M troglitazone (TRO) followed by media modifications 
described by Pratt et al. (2010).  Secondary differentiation media (DMEM, 5% FCS, 2X 
AB/AM, insulin at 2.5 g/mL, 5 M TRO) supplemented with 0 mM or 0.3 mM linoleic 
acid was applied from d 2 to 12.  Undifferentiated cells were harvested on d 2 and 
differentiated cells supplemented with or without linoleic acid were harvested on d 2, 6, 
and 12 for fatty acid and mRNA expression analysis.  All treatments were performed in 
duplicate for each SV culture. 
 Fatty acids.  Cellular fatty acids were extracted as described by Folch et al. 
(1957) and transmethylated according to Park and Goins (1994).  Fatty acid methyl esters 
were analyzed using an Agilent 6850 gas chromatograph equipped with an Agilent 




were accomplished using a 100-m Supelco SP-2560 (Supelco, Inc., Bellefonte, PA) 
capillary column (0.25 mm i.d. and 0.20 m film thickness) according to Duckett et al. 
(2002).  Individual fatty acids were identified by comparison of retention times with 
standards (Sigma, St. Louis, MO; Matreya, Pleasant Gap, PA).  Fatty acids were 
quantified by incorporating an internal standard, methyl tricosanoic (C23:0) acid, into 
each sample during methylation and expressed as a weight percentage of total fatty acids 
per well.  
Gene Expression.  Total cellular RNA was isolated from cells using the mirVana 
microRNA Isolation kit (Ambion, Austin, TX) according to manufacturer‟s instructions 
and RNA quality as described by Duckett et al. (2009).  Quality was assessed using 
Nanodrop 2000 Spectrophotometer (Thermo Fisher Scientific, Inc., Waltham, MA); 
tcRNA samples used in real-time PCR (qRT-PCR) had a 260:280 absorbance ratio > 1.7.  
Real-time qRT-PCR was conducted using an Eppendorf MasterCycler ep realplex 
(Westbury, NY) with the QuantiTect SYBR Green RT-PCR One Step Kit (Qiagen, 
Valencia, CA) according to the manufacturer‟s directions.  Two genes, glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) and β-actin, were evaluated as housekeeping genes 
for data normalization (Duckett et al., 2009).  To determine the appropriate housekeeping 
gene to be used to normalize the data, the cycle threshold values (CT) for GAPDH, β-
actin, and all target genes per sample were entered into the BESTKEEPER program 
(http://www.gene-quantification.info). The program determines the most stable 
housekeeping gene to be used for normalization by repeated pair-wise correlation and 




coefficient of 0.99 (P < 0.001) in the analysis and were suitable for data normalization.  
Primers for bovine mRNAs were designed using Primer 3 software 
(http://frodo.wi.mit.edu/primer3/).  Primer sets were first evaluated according to Duckett 
et al. (2009) to verify identity.  Genes of interest were those involved in fatty acid 
biosynthesis, acetyl-CoA carboxylase (ACC), fatty acid synthase (FASN), and SCD1, as 
well as their transcription factors, peroxisome proliferator-activated receptor gamma 
(PPAR  and sterol regulatory element binding protein (SREBP).  Additionally, glucose 
transporter 4 (GLUT4) was gene expression was analyzed. 
Statistical Analysis.  The data were analyzed using Proc GLM procedure of SAS 
9.2 (Cary, NC) for treatment comparisons over time.  A two-way analysis of variance 
(ANOVA) was performed as a completely randomized design with factors consisting of 
insulin (0 or 2.5 g/mL) and linoleic acid (0 or 0.3 mM C18:2 n-6) for Experiment 1 and 
linoleic acid (0 or 0.3 mM C18:2 n-6) and day of differentiation (d 2, 6, or d 12) for 
Experiment 2.  Least squares means are computed and separated statistically using 
Fisher‟s Protected LSD test.  When the overall F-test for the treatment effect was 
significant (P ≤ 0.05), a t-test was performed to discern the differences among treatments 
by using the PDIFF option of the LSMeans statement.  For gene expression data, 
normalized CT values were subjected to ANOVA, as described above.  Additionally, 
relative gene expression data was analyzed using Pair-wise Fixed Reallocation 




RESULTS AND DISCUSSION 
The differentiation hormones and media used in our experiment have been tested 
for their efficacy in inducing differentiation in bovine SV cultures (Aso et al., 1995; 
Grant et al., 2008a and b; Lengi and  Corl, 2010).  Classically, fibroblastic preadipocytes 
change shape from stellate to round and accumulate lipid (Napolitano, 1963), in addition 
to changes in gene expression (Taniguchi et al., 2008a).  Previously, our SV cultures 
displayed characteristic changes in morphology, lipid-filling, and adipogenic gene 
expression upon hormonal treatment, consistent with adipocyte differentiation (Pratt et 
al., 2010).  In the current study, cells changed shape from fibroblastic to round following 
differentiation and became lipid-filled, especially with fatty acid supplementation (data 
not shown).   
Experiment 1.  There was a main effect of linoleic acid supplementation on 
palmitic (C16:0), palmitoleic (C16:1), stearic (C18:0), oleic (C18:1 cis-9), C18:2 n-6, 
linolenic acid (C18:3 n-3), and total fatty acid levels (Figure 1).  Each fatty acid 
identified, with the exception of C18:2 n-6, decreased (P < 0.05) in response to linoleic 
acid supplementation.  This suggests that the presence of abundant PUFA could decrease 
lipogenesis or stimulate -oxidation of endogenous fatty acids.  Insulin supplementation 
did not affect (P > 0.05) fatty acid composition, although there was a trend (P = 0.07) for 
increased C18:2 n-6 in insulin-treated cultures.   
Stearoyl-CoA desaturase 1 (SCD1) is the enzyme responsible for creating a 
double bond at the 
9
 position of several fatty-acyl CoA and its preferred substrates are 




certain fatty acids, including linoleic acid (Ntambi, 1995).  The level of linoleic acid 
supplementation used in this study was based on a dose titration by Sessler et al. (1996) 
for arachidonic (C20:4 n-6) inhibition on SCD1.  They tested the effects of several fatty 
acids on SCD1 mRNA expression in 3T3-L1 adipocytes, an immortalized murine cell 
line.  In addition to arachidonic acid, 0.3 mM linoleic acid and linolenic (C18:3 n-3) acids 
reduced SCD1 mRNA expression (Sessler et al., 1996).  In our study, we also found 
SCD1 mRNA expression to be down-regulated in linoleic acid supplemented cells 
(Figure 2), in addition to desaturation indices (Figure 3). 
Experiment 2.  Indicative of functional adipocytes cultures, total cellular fatty 
acids increased (P < 0.001) over time in both groups, but to a greater extent in linoleic 
acid-treated cells (P < 0.001, Table 1).  Linoleic acid incorporation into the cells was 
demonstrated by increased (P < 0.01) C18:2 n-6 in linoleic acid-treated cells compared 
with unsupplemented on both a percent and gravimetric basis on d 6 and d 12 (Table 1 
and 2).  Corresponding with increased C18:2 n-6 in linoleic acid-treated cells, C16:0, 
C18:0, C18:1 cis-9, and C18:3 n-3 fatty acids decreased (P < 0.001) on a percent basis 
for both d 6 and d 12 compared with unsupplemented cells (Table 2).   
Predominate fatty acids of interest in this study were products of de novo fatty 
acid synthesis, C16:0 and C18:0, products of desaturation, C16:1 and C18:1 cis-9, and 
PUFA, C18:2 n-6 and C18:3 n-3.   For each of these fatty acids, there was a significant 
interaction (P > 0.05) between linoleic acid supplementation and day, indicating that fatty 
acid composition changed over time within differentiating bovine adipocytes and linoleic 




obvious examples of this are the monounsaturated fatty acids (MUFA), C16:1 and C18:1 
cis-9.  Both MUFA were increased (P < 0.05) on a gravimetric basis by d 6 and were 
greatest in d 12 in unsupplemented cells; in linoleic acid-treated cells, however, MUFA 
did not change over time (P > 0.05, Table 1).  The desaturation indices of the bovine 
adipocytes cultures followed a similar pattern.  Both MUFA/SFA and C18:1 cis-9/C18:0 
indices increased (P < 0.01) over time for unsupplemented cells, but decreased (P < 0.05) 
over time in linoleic acid-treated cells.  The C16:1/C16:0 ratio also followed this trend 
numerically, however, was not statistically significant.   
Gene Expression.  Messenger RNA levels of SCD1, aP2, and PPAR , 
differentation-associated genes, did not differ (P > 0.05) due to linoleic acid 
supplementation compared with unsupplemented cells.  An indicator of differentiation 
and desaturation, SCD1 mRNA expression was up-regulated (P < 0.05) 2 d after 
differentiation media was applied.  From d 2 to d 6 SCD gene expression decreased (P < 
0.05), but then up-regulated (P < 0.05) to an intermediate level between d 6 and d 12 
(Figure 4).  Adipocyte protein 2 mRNA was also up-regulated (P < 0.05) on d 2 in 
response to differentiation, but lower (P < 0.05) on d 6 and 12 compared with d 2.  
Expression of PPAR  did not differ (P > 0.05) in d 2 and 6 cells compared with 
undifferentiated cells, but was up-regulated (P < 0.05) on d 12.  There was an interaction 
of linoleic acid supplementation and day of harvest for SREBP, a lipogenic transcription 
factor.  Gene expression of SREBP was decreased (P < 0.05) in unsupplemented cells on 
d 6 and d 12 compared with d 2, but was up-regulated (P < 0.05) in linoleic acid-treated 




associated genes were not affected by linoleic acid supplementation.  Both GLUT4 and 
FASN mRNA were up-regulated (P < 0.05) on d 12 compared with d 2 and 
undifferentiated cells.   
Primary cell lines were confirmed to have a high proportion of preadipocytes 
through observation of morphological changes and staining of organized lipid droplets 
within cells, gene expression changes, and lipid profiles. Two days after differentiation 
media was applied, cultures demonstrated characteristic shape-change, from fusiform to 
spherical, and adipogenic gene expression through up-regulated adipocyte protein 2 (aP2) 
and SCD mRNA, which are markers for differentiation along with PPAR  (Chawla et al., 
1994; Ohsaki et al., 2007).  The master regulator of adipocyte regulation is classically 
stated as PPAR ; however, most of this work has been conducted in murine species 
(Ntambi and  Kim, 2000).  We did not observe marked up-regulation of PPAR  gene 
expression in this study.  Similarly, Lengi and Corl (2010), when using the same 
hormonal induction of differentiation in primary bovine stromal vascular cultures, failed 
to detect up-regulated PPAR  gene expression.  Despite a lack of PPAR  up-reguation in 
differentiated cultures, active lipogenesis was confirmed through increased labeled 
acetate incorporation into lipids (Lengi and  Corl, 2010).  Similarly, our cultures 
demonstrated lipid-filling, creation de novo lipid synthesis products, C16:0 and C18:0, 
and uptake exogenous linoleic acid.  Additionally, in the absence of differentiation 
media, preadipocyte cultures had limited uptake of supplemented lipid (data not shown) 




cells.  The responses we observed in our differentiated cultures were comparable with the 
literature (Aso et al., 1995; Ohsaki et al., 2007; Grant et al., 2008a).   
Fatty acid profiles indicated that adipocytes absorbed linoleic acid from the media 
and began taking up and synthesizing fat within 6 d of applying the primary 
differentiation media.  Increased fatty acids over time in unsupplemented cells suggests 
fatty acid sythethis, absorption from the media, or both was occurring.  Reduced fatty 
acids over time due to linoleic acid supplementation could indicate a down-regualtion of 
lipogenesis, an up-regulation of -oxidation, or both.  Regulation of fatty acid synthesis 
can occur at many different levels.  Each enzyme in the lipogenesis pathway can be 
regulated in addition to cellularity of adipose tissue.  Fatty acid synthesis begins with the 
committed step of adding a carboxyl group to acetyl-CoA, forming malonyl-CoA, by 
ACC, which can be regulated allosterically and by phosphorylation.  Fatty acid synthase 
is a large, multimeric protein that sequentially adds acetate to malonyl-CoA or a fatty 
acyl-CoA until the fatty acid reaches a length of 16 carbons, C16:0.  It is primarily 
regulated through transcription.  Up-regulation of FASN mRNA in differentiated cultures 
suggests lipogenic gene expression does not change until d 12; however, micrograms of 
fatty acids were increased by d 6.  Despite increasing C16:0 over time in linoleic acid-
treated cultures, there was no difference in gene expression of FASN compared with 
unsupplemented cells.  Therefore, from this data, it is unclear whether linoleic acid 
affects fatty acid synthesis.  In addition, biosynthesis pathways may be regulated at a 
level other than gene transcription.  In fact, C16:1, C18:0 and C18:1 cis-9 all decreased 




lipogenic effect of linoleic acid supplementation or an increase in -oxidation.  Though 
not significant, lipogenic gene and protein expression were numerically greater in bovine 
adipocytes treated with 50 M linoleic acid on d 8 compared with non-fatty acid added 
controls (Lengi and  Corl, 2010).  Fatty acid data was not reported by Lengi and Corl 
(2010), so comparison of lipid profiles was not possible.   
Stearoyl-CoA desaturase is the rate-limiting enzyme in the production of MUFA 
from SFA.  The preferred substrates for SCD are C16:0 and C18:0, which become C16:1 
and C18:1 cis-9, respectively.  Because of its role in biosynthesis of MUFA, SCD can 
impact membrane fluidity and composition of stored triglycerides by changing the ratio 
of MUFA/SFA.  Previously, fatty acid indices of MUFA/SFA have been correlated to 
SCD mRNA expression (Peter et al., 2009).  Even though SCD gene expression was not 
affected by linoleic acid supplementation in Experiment 2, desaturase activity appeared to 
decrease in linoleic acid-treated cells based on a reduction in the C18:1 cis-9/C18:0 ratio.  
In unsupplemented cells, C16:1/C16:0 ratio did not change over time, but the C18:1 cis-
9/C18:0 ratio increased over time, suggesting C18:0 may be a preferential substrate for 
desaturation compared with C16:0 in bovine adipocytes cultures or that synthesis rates of 
C16:0 closely mimic desaturation rates.   
As reviewed by Ntambi and Miyazaki (2004), polyunsaturated fatty acids (PUFA) 
decrease SCD expression in murine cells.  In bovine adipose tissue, however, increasing 
linoleic acid from the diet is associated with up-regulation of SCD mRNA in 
subcutaneous adipose tissue (Duckett et al., 2009).  Transcription of SCD mRNA is 




promoter region of the SCD gene, but it is also regulated by many other factors (Eberlé et 
al., 2004; Lay et al., 2002).  We suspect timing and level of fatty acid supplementation to 
have a key role in linoleic acid‟s influence on SCD expression in bovine adipocyte 
cultures.  Overall, expression of SCD mRNA was up-regulated prior to changes in fatty 
acid desaturation indices.  However, desaturation indices are not always good indicator of 
SCD activity (Archibeque et al., 2005).  This could indicate a lag in the translation of 
functional SCD1 protein or an additional level of regulation, microRNA for instance.   
In conclusion, fatty acid composition changes with respect to time following 
induction of differentiation and also reflects changes in fatty acid composition of the 
media.  Insulin supplemented at the current dose was not effective at altering lipogenic 
gene transcription or fatty acid profiles of bovine adipocyte cultures.  Supplementing 
culture media with linoleic acid reduced SCD1 transcription at d 18 and decreased 
desaturation indices at d 6, 12, and 18.  Bovine adipocyte cultures actively desaturate 
fatty acids, which leads to changes in fatty acid composition of the cultures.  In addition, 
by d 6, fatty acid profiles of adipocyte cultures are sensitive to lipogenic regulation by 
exogenous fatty acid administration.  Based on our data of fatty acid uptake and mRNA 
expression changes of differentiation-associated proteins, we propose to time future 





Figure 1.  Main effect of linoleic acid supplementation (0 or 0.3 mM C18:2 n-6) on 





Figure 2.  Main effect of linoleic acid supplementation (0 or 0.3 mM C18:2 n-6) on 
stearoyl-CoA desaturase 1 (SCD1) mRNA expression in bovine adipocyte cultures on d 





Figure 3.  Desaturation indices of bovine adipocytes treated with 0 or 0.3 mM linoleic 




Table 1.  Gravimetric fatty acid composition of bovine adipocytes supplemented with 0 or 0.3 mM linoleic acid (C18:2 n-6) 
over time.  
                        
Fatty acid, 
g/well 
0 mM Linoleic Acid   0.3 mM Linoleic Acid   p-value 
d 2 d 6 d 12   d 2 d 6 d 12 SEM 
Linoleic 
Acid  Day  Interaction 
C16:0 5.46d 12.04c 24.87a   5.46d 15.92b 23.87a 0.93 0.230 < 0.001 0.046 
C16:1 0.34c 0.86b 1.98a   0.34c 0.64bc 0.24c 0.15 < 0.001 < 0.001 < 0.001 
C18:0 8.01c 12.12b 22.73a   8.01c 11.56b 13.03b 0.97 < 0.001 < 0.001 < 0.001 
C18:1 cis-9 5.36c 14.34b 33.53a   5.36c 6.30c 5.29c 0.71 < 0.001 < 0.001 < 0.001 
C18:2 n-6 3.70c 5.87c 11.56c   3.70c 71.48b 99.08a 4.26 < 0.001 < 0.001 <0.0001 
C18:3 n-3 NDc 0.59b 1.54a   NDc 0.02c NDc 0.18 < 0.001 0.002 0.002 
Total fatty acids 63.93c 125.51bc 163.30ab   63.93c 247.05a 223.97ab 26.8 0.027 0.130 0.432 
                        
C16:1/C16:0 0.066ab 0.071ab 0.08a   0.066ab 0.041ab 0.010b 0.02 0.046 0.819 0.424 
C18:1 cis-
9/C18:0 0.76c 1.21b 1.48a   0.76c 0.56d 0.41d 0.07 < 0.001 < 0.001 0.013 
MUFA/SFA 0.44c 0.63b 0.75a   0.44c 0.25d 0.15e 0.03 < 0.001 < 0.001 < 0.001 







Figure 4.  Real-time qRT-PCR data of bovine adipocytes cultured to d 2, 6, or 12 with 0 
mM or 0.3 mM linoleic acid (C18:2 n-6).  A. Expression of differentiation-associated and 
transcription factor mRNA [stearoyl-CoA desaturase 1 (SCD1), adipocyte protein 2 
(aP2), and peroxisome proliferator-activated receptor  (PPAR .  B.  Expression of 
energy intake-associated and lipogenic mRNA [sterol regulatory element binding protein 
(SREBP), glucose transporter 4 (GLUT4), fatty acid synthase (FASN)].  CT values were 
normalized to glyceraldehydes-3-phosphate dehydrogenase and set to relative expression 
of undifferentiated cultures (Undiff) on d 2.  
a-d
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CHAPTER 3:  SUPPLEMENTAL PALMITOLEIC ACID 
(C16:1 cis-9) REDUCES LIPOGENESIS AND 




Our objective was to determine if palmitoleic (C16:1 cis-9) acid supplementation 
to primary bovine adipocytes regulates lipogenic gene expression and rates of 
lipogenesis.  Stromal vascular cells were isolated from 3 cattle, propagated, and frozen 
for use in this study.  Cells were passaged 4 times, allowed to reach confluence, held for 
2 d, and then differentiated with a standard hormone cocktail (d 0).  At d 2, secondary 
differentiation media containing 1 of 4 levels of palmitoleic acid (0, 50, 150, or 300 μM) 
was added for 10 d.  Cells were harvested on d 6 and 12 to assess fatty acid levels and 




C18:0 stable isotopes were added on d 6 to 
measure lipogenesis and desaturase activity, respectively.  Levels of C16:1 and total fatty 
acids increased (P < 0.05) linearly in response to palmitoleic acid supplement.  Levels of 
C18:1 cis-11 and C20:1 cis-13 also increased (P < 0.01) in response to supplementation 
suggesting elongation of palmitoleic acid in vitro.  Levels of C16:1, C18:1 cis-11 and 
total fatty acids were also greater (P < 0.05) at d 12 compared to d 6.  In contrast, C16:0, 
C18:0, and C18:1 cis-9 levels decreased (P < 0.05) in response to palmitoleic acid 
supplementation and were not affected (P > 0.05) by harvest day.  The ratio of C18:1 cis-
9/C18:0 and fractional synthetic rate (FSR) of desaturation decreased (P < 0.05) in 
response to increasing palmitoleic acid supplementation.  In addition, FSR of lipogenesis 




determined by qRT-PCR for stearoyl-CoA desaturase 1 (SCD1), fatty acid synthase 
(FASN), and elongase protein 6 (ELOVL6) genes were reduced (P < 0.05) by palmitoleic 
acid supplementation.  Expression of a -oxidation gene, carnitine palmitoyltransferase 
1A (CPT1A), was up-regulated (P < 0.05) with palmitoleic acid supplementation in a 
dose response manner.  Supplementation of palmitoleic acid to bovine adipocytes results 
in increased incorporation of this fatty acid and its elongation products into the adipocyte, 
which down-regulates SCD1, FASN, and ELOVL6 to decrease lipogenesis and 
desaturation and up-regulates CPT1A to increase β-oxidation.  These results suggest that 
palmitoleic acid, an end-product of desaturation, can act as a regulator of lipogenesis, 





Over the past decade, researchers have begun to view white adipose tissue, not as 
an inert energy storage site, but as a complex, metabolically active tissue (McGillis, 
2005).  Excess adipose tissue is not advantageous to human health, with regard to 
common medical disorders associated with obesity, or to livestock producers, who strive 
for a balance between maximal intramuscular fat and minimal subcutaneous fat which 
influence beef quality and yield grades, respectively.  In addition, interest in fatty acid 
composition of meat and milk products has increased with concerns of saturated fatty 
acids (SFA) in the human diet. Research shows that adipocytes in white adipose tissue 
produce and secrete leptin (Flier, 1998), adipokines (MacDougald and  Burant, 2007), 
and lipokines (Cao et al., 2008) that coordinate systemic metabolism.   
Cao et al. (2008) identified palmitoleic (C16:1 cis-9) acid as a lipokine that 
increases insulin sensitivity in skeletal muscle and decreases lipogenesis in liver of mice. 
In this study, exogenous administration of palmitoleic acid to mice reduced lipogenic 
gene expression in the liver and increased insulin signaling in skeletal muscle.  In 
humans, circulating palmitoleic acid level is strongly associated with abdominal obesity 
in children (Okada et al., 2005) and adults (Gong et al., 2010), and predictor of insulin 
sensitivity in adults (Stefan et al., 2010).  In finishing beef cattle, the correlation between 
tissue palmitoleic and oleic (C18:1 cis-9) acid concentrations and carcass fat content are 
high (r = 0.68 and 0.81, respectively; Duckett unpublished data).  In rodents and non-
obese humans, the liver serves as the primary site of de novo lipogenesis; conversely, 




1980; Smith and  Crouse, 1984).  Palmitoleic acid in circulation and adipose tissues 
originates predominately from de novo fatty acid synthesis as dietary sources of C16:1 
are minor.  Therefore, we hypothesize that palmitoleic acid supplementation to bovine 




MATERIALS AND METHODS 
Cell Culture.  Primary bovine stromal vascular (SV) cultures were harvested from 
adipose tissue of 18 mo old Angus crossbred cattle as described by Pratt et al. (2010) 
using slight modifications of methods described by Hirai et al. (2007).  Cells were plated 




 and passaged every 2 to 4 d when 60% confluent.  Cells were 
incubated at 37°C under 5% CO2 humidified atmosphere with media [Dulbecco‟s 
modified eagles medium (DMEM) containing 10% fetal calf serum (FCS), and 2X 
antibiotic/antimycotic (AB/AM; containing 10,000 U/mL penicillin G, 10,000 g/mL 
streptomycin, and 25 g/mL amphotericin B)] replacement every 2 d.  After 4 passages, 
cell lines were stored in liquid nitrogen at 1 x 10
6
 cells/mL in freezing media (DMEM, 
20% FCS, and 10% dimethyl sulfoxide) for later use.   
Treatments.  Individual cultures from 3 animals were used in duplicate for this 







.  Cells were allowed to reach confluence, held for 2 d, and differentiated 
on d 0 with DMEM containing 5% FCS, 2X AB/AM, 2.5 g/ml insulin, 0.5 mM 2-
isobutyl-1-methylaxanthine (IBMX), 0.25 M dexamethasone (DEX), 5 M troglitazone 
(TRO), and 10 mM acetate (Hirai et al., 2007; Pratt et al., 2010).  Secondary 
differentiation media (DMEM, 5% FCS, 2X AB/AM, 2.5 g/mL insulin, 5 M TRO, and 
10 mM acetate) was applied for 4 (d 6) or 10 d (d 12) along with palmitoleic acid (C16:1 
cis-9) at varying levels (0, 50, 150, or 300 M).  Palmitoleic acid was bound to bovine 




Cells were harvested on d 6 and d 12 for fatty acid composition and lipogenic gene 
expression.  Before trypsin was applied, media was removed and cells were rinsed 3 
times with PBS. 
The differentiation hormones and media used in our experiment have been tested 
for their efficacy in inducing differentiation in bovine SV cultures (Aso et al., 1995;  
Grant et al., 2008a and b; Lengi and  Corl, 2010).  Classically, preadipocytes change 
shape from fibroblastic to round and accumulate lipid (Napolitano, 1963), in addition to 
changes in gene expression (Taniguchi et al., 2008).  Previously, our SV cultures 
displayed characteristic changes in morphology, lipid-filling, and adipogenic gene 
expression upon hormonal treatment, consistent with adipocyte differentiation (Pratt et 
al., 2010).  In the current study, cells changed shape from fibroblastic to round following 
differentiation and became lipid-filled with fatty acid supplementation (Figure 1).   
 Fatty acids.  Cellular fatty acids were extracted and transmethylated as described 
by Folch et al. (1957) and Park and Goins (1994), respectively.  Fatty acid methyl esters 
(FAME) were analyzed using an Agilent 6850 gas chromatograph (GC) equipped with an 
Agilent 7673A automatic sampler (Agilent Technologies, Inc., Santa Clara, CA).  
Separations were accomplished using a 100-m Supelco SP-2560 (Supelco, Inc., 
Bellefonte, PA) capillary column (0.25 mm i.d. and 0.20 m film thickness) according to 
Duckett et al. (2002).  Individual fatty acids were identified by comparison of retention 
times with standards (Sigma, St. Louis, MO; Matreya, Pleasant Gap, PA).  Fatty acids 




into each sample during methylation and expressed as a weight percentage of total fatty 
acids per well.  
Lipogenesis.  To measure lipogenesis in vitro, we added stable isotope labeled 
acetate (2.5 mM 1-
13
C2) to cultures treated with 0, 150, and 300  C16:1 on d 6 for 0, 
6, 12, and 24 h.  At harvest, cells were placed directly into 2:1 chloroform:methanol 
(vol/vol) to terminate all enzymatic activity.  Fatty acid methyl esters were prepared as 
stated above for analysis with an Agilent 6890N GC equipped with an Agilent 5973 mass 
spectrometer (MS) using a 100-m Varian CP7489 (Varian Instruments Inc., Walnut 
Creek, CA) capillary column (0.25 mm i.d. and 0.20 μm film thickness).  Samples were 
run in the chemical ionization mode with He as the carrier gas and CH4 as the reagent 
gas.  Ions of mass-to-charge ratio (m/z) 270 (m), 271 (m + 1), and 272 (m + 2) were 
selectively measured to calculate the isotopic enrichments of C16:0.   
Enrichment of a sample treated with stable isotope can be calculated by several 
different methods.  Because we were interested in calculating lipogenic rate in terms of 
the formation of a fatty acid polymer, C16:0, from repeating units of acetate, we used 
Mass Isotopomer Distribution Analysis (MIDA), which is ideal in this application (Wolfe 
and  Chinkes, 2005).  In essence, MIDA estimates the precursor enrichment pool 
(MPEprecursor) based on probabilities and uses it to calculate a fractional synthetic rate 
(FSR) of the product.  We calculated the relative abundance (RA) of singly (m + 1) and 
doubly (m + 2) labeled C16:0 to unlabeled (m) C16:0 isotopomers.  To account for 
background noise and natural abundance of 
13
C isotope, the tracer-to-tracee ratio (TTR) 
was calculated as TTRC16:0  =  (RAsample – RAblank) * (1 – A)
n 






C, A = 0.011, and n was the number of C in the fatty acid molecule, n = 
16 (Wolfe and  Chinkes, 2005).  Samples that were not exposed to labeled isotope served 
as „blanks‟.  Precursor enrichment in molar percent excess (MPE) was estimated by: 
 
MPEprecursor     =             2 × (TTR(m + 2) / TTR(m + 1)) 
       (p – 1) + (2 × (TTR(m + 2) / TTR(m + 1)) 
where, p is the number of precursor monomers present in the polymer, p = 8.  Finally, our 
estimate of lipogenesis could be derived by calculating FSR (Wolfe and  Chinkes, 2005). 
FSRlipogenesis   =                         TTRC16:0, time1 – TTRC16:0, time0 
     (p × MPEprecursor) (1 - MPEprecursor)
p-1
 (time1 – time0) 
 
Desaturation.  Stearoyl-CoA desaturase 1 (SCD1) is the enzyme responsible for 
creating a double bond at the 
9
 position of several fatty-acyl CoA and its preferred 
substrates are C16:0 and C18:0 (Enoch et al., 1976).  Stearoyl-CoA desaturase 
transcription and activity can regulated by certain fatty acids (Ntambi, 1995), but the 
effect of palmitoleic acid supplementation on SCD1 activity has not been reported to 
date.   Traditionally, western blotting is used to detect protein abundance; however, we 
have not been successful in blotting for bovine SCD1 using commercially available 
antibodies designed for human and mouse.  Therefore, we focused our efforts on in vitro 
measurement of SCD1 activity using stable isotopes.  Initially, we added 20 M 1-
13
C18:0 to cultures on d 6 as described above.  Enrichment of C18:0 was detected by 6 h 
post-inclusion of tracer; however, TTR of C18:1 cis-9 was not evident in cultures (data 




 C16:1 and increased the amount of tracer to 100 M 1-
13
C18:0 on d 6.  Samples were 
prepared and analyzed as described above for analysis with GC-MS.  Ions of mass-to-
charge ratio (m/z) 298 (m) and 299 (m + 1) were selectively measured to calculate the 
isotopic enrichments of C18:0.  Similarly, isotope abundance of 296 (m) and 297 (m + 1) 
was measured for C18:1 cis-9.  Since tracer enrichment can be measured in this case and 
the product of the SCD reaction is not a polymer of the tracer, it was not necessary to use 
MIDA.  The FSR was calculated for rate of desaturation using the precursor enrichment, 
MPEC18:0. 
FSRdesaturation   =      TTRC18:1 cis-9, time1 – TTR C18:1 cis-9, time0  
           MPEC18:0 × (time1 – time0) 
Gene Expression.  Total cellular RNA was isolated from cells using the mirVana 
microRNA Isolation kit (Ambion, Austin, TX) according to manufacturer‟s instructions 
and RNA quality as described by Duckett et al. (2009).  Quality was assessed using 
Nanodrop 2000 Spectrophotometer (Thermo Fisher Scientific, Inc., Waltham, MA) and 
Agilent Bioanalyzer 2100.  All tcRNA samples used in real-time PCR (qRT-PCR) had a 
260:280 absorbance ratio > 1.8 on the Nanodrop and RNA integrity number > 8.0 (1.0 to 
10.0 scale) using Agilent RNA 6000 Nano kit.  Real-time qRT-PCR was conducted using 
an Eppendorf MasterCycler ep realplex (Westbury, NY) with the QuantiTect SYBR 
Green RT-PCR One Step Kit (Qiagen, Valencia, CA) according to the manufacturer‟s 
directions.  Two genes, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-
actin, were evaluated as housekeeping genes for data normalization (Duckett et al., 2009).  




cycle threshold values (CT) for GAPDH, β-actin, and all target genes per sample were 
entered into the BESTKEEPER program (http://www.gene-quantification.info). The 
program determines the most stable housekeeping gene to be used for normalization by 
repeated pair-wise correlation and regression analysis (Pfaffl et al., 2002). Both GAPDH 
and β-actin exhibited a correlation coefficient of 0.99 (P < 0.001) in the analysis and 
were suitable for data normalization.  Primers for bovine mRNAs were designed using 
Primer 3 software (http://frodo.wi.mit.edu/primer3/).  Primer sets were first evaluated 
according to Duckett et al. (2009) to verify identity.   Genes of interest for this study were 
those involved in fatty acid biosynthesis including acetyl-CoA carboxylase (ACC), fatty 
acid synthase (FASN), fatty acid elongase (ELOVL) -5 and -6, SCD1, sterol regulatory 
element binding protein-1c (SREBP), and carnitine palmitoyl-transferase 1A (CPT1A).  
Statistical Analysis.  The data were analyzed using Proc GLM procedure of SAS 
9.2 (SAS Institute Inc., Cary, NC) for treatment comparisons over time.  A two-way 
analysis of variance (ANOVA) was performed as a completely randomized design with 
factors fatty acid level (0, 50, 150, and 300 M C16:1), day (d 6 and d 12) or time (0, 6, 
12, and 24 h), and two-way interaction.  Least squares means were computed and 
separated statistically using Fisher‟s Protected LSD test.  In addition, linear regression 
was performed using the bivariate fit model of JMP Version 7 (SAS Institute Inc.).  
Relative gene expression data was analyzed using Pair-wise Fixed Reallocation 




RESULTS AND DISCUSSION 
Fatty acids.  We successfully incorporated our fatty acid supplement into bovine 
adipocyte cultures based on detection of increasing amounts of C16:1 in palmitoleic acid-
treated cells after all media was removed (Figure 2).  Rates of palmitoleic acid 
incorporation into the adipocytes were 0.24 and 0.61 μg/well per M supplemented 
palmitoleic acid for d 6 and 12 respectively.  After completion of the fatty acid analysis, 
we discovered high concentrations of fatty acids believed to be C18:1 cis-11 and C20:1 
cis-13.  In order to confirm identity, ion masses were checked with GC-MS and samples 
were spiked with standards of known identity.  The identity of these peaks were 
confirmed as being C18:1 cis-11 and C20:1 cis-13.  A significant interaction (P < 0.001) 
between level of palmitoleic acid supplementation and day of harvest was present for 
total fatty acids, C16:1, C18:1 cis-11, and C20:1 cis-13 (Figure 2).  Each of these fatty 
acids gravimetrically increased (P < 0.01) in response to higher levels of palmitoleic acid 
supplementation and the magnitude of response was greater (P < 0.01) on d 12 than d 6.  
No other fatty acid peaks detected showed a similar pattern of response (P > 0.05).  As 
C18:1 cis-11 and C20:1 cis-13 were not present in high concentrations in control cells 
and they increased dramatically in cultures supplemented with palmitoleic acid, we 
suspect they were elongated from palmitoleic acid.   
After accounting for any endogenous levels of C16:1, C18:1 cis-11, and C20:1 
cis-13 in our cultures, we estimated the percentage of supplemental palmitoleic acid that 
was elongated.  In the 50 M palmitoleic acid-treated cells on d 6, 66 ± 2% of palmitoleic 




acid supplementation, the percent of palmitoleic acid converted to C18:1 cis-11 and 
C20:1 cis-13 decreased (P < 0.01) to 55 ± 2% and 49 ± 2% for 150 and 300 M 
treatment levels, respectively.  Results were similar for d 12 cultures in that the percent of 
palmitoleic acid elongated was 69 ± 3%, 63 ± 2%, and 54 ± 2% for the 50, 150, and 300 
M palmitoleic acid treatment levels, respectively.  Despite the linear incorporation of 
C16:1 into the adipocytes, the percentage elongated into C18:1 cis-11 and C20:1 cis-13 in 
bovine adipocytes was curvilinear suggesting that the elongase reaction was limited by 
another factor other than substrate availability.   
There was also an interaction (P < 0.05) between level of palmitoleic acid 
supplementation and day of harvest for linoleic (C18:2 n-6) acid (Figure 3).  On d 12, 
linoleic acid content did not differ (P > 0.05) with palmitoleic acid supplementation 
(Table 1).  On d 6, linoleic acid content decreased (P < 0.05) with palmitoleic acid 
supplementation.  Stearic (C18:0) acid content was lower (P < 0.05) at 50 and 300 μM 
compared to controls (0 μM).  Oleic (C18:1 cis-9) and arachidonic (C20:4 n-6) acids 
were lower (P < 0.05) in palmitoleic acid supplemented cells, regardless of 
supplementation level.  Palmitic (C16:0) acid content did not differ (P > 0.05) with 
palmitoleic acid supplementation. 
Lipogenesis.  We were able to detect enrichment of C16:0, calculated by TTR, in 
cells treated with 1-
13
C2 in the media on d 6.  There was a significant interaction (P < 
0.01) of TTRC16:0 between level of palmitoleic acid supplementation and time of labeled 
acetate incubation.  All palmitoleic acid treatment levels had TTRC16:0 greater than zero 




TTRC16:0 compared with 0 M palmitoleic acid-treated cells and numerically lower 
TTRC16:0 than 300 M palmitoleic acid-treated cells (Figure 4).  At 24 h after 1-
13
C2 
treatment, TTRC16:0 of 0, 150, and 300 M cells differed (P < 0.001) from each other. 
Similarly, FSRC16:0 from 0 to 24 h following labeled acetate treatment was reduced (P < 
0.05) approximately 45 and 30% by 150 and 300 M palmitoleic acid supplementation, 
respectively.  Therefore, lipogenesis, as measured by the rate of labeled acetate 
incorporation into the primary product of de novo fatty acid synthesis, C16:0, was 
decreased by palmitoleic acid supplementation.   
Overall, micrograms of C16:0 present in our cultures did not differ due to 
palmitoleic acid treatment, but synthesis of 
13
C16:0 from labeled 
13
C acetate was reduced 
in palmitoleic acid-treated cells.  Unchanged micrograms of C16:0 could indicate that 
C16:0 was not desaturated or elongated, but was conserved as a SFA in palmitoleic acid-
treated cells.  The ratio of MUFA/SFA is a critical factor effecting membrane fluidity and 
survivability of a cell (Ntambi and  Miyazaki, 2004).   
Desaturation.  The ratios of monounsaturated fatty acids (MUFA) to SFA are 
often calculated as indicators of desaturation and have been associated with SCD1 
activity (Baumgard et al., 2002; Mosley and  McGuire, 2007).  Since our fatty acid 
treatment confounded the C16:1/C16:0 ratio and peaks for C14:1 and C14:0 were not 
detectable, we used C18:1 cis-9/C18:0 ratio as our desaturation index.  There was no 
main effect of harvest day on C18:1 cis-9/C18:0 ratio, but level of palmitoleic acid 
supplementation reduced (P < 0.001) the C18:1 cis-9/C18:0 ratio (Table 2).  The 50, 150, 




ratio compared with 0 M palmitoleic acid-supplemented cells.  In addition, cells treated 
with 300 M palmitoleic acid had reduced (P < 0.05) desaturation index compared with 
cells treated with 50 M palmitoleic acid.  These results suggest that desaturation was 
decreased by palmitoleic acid supplementation; however, desaturation ratios are not 
always reflective of SCD1 activity (Archibeque et al., 2005).   
To get a more accurate measurement of desaturation activity than simply using a 
desaturation index, we measured desaturation of stable isotope tracer in our cultures. We 
were able to detect significant enrichment of C18:0 in our cells 6 h following 1-
13
C18:0 
addition.  There was no effect of palmitoleic acid supplementation on TTRC18:0, only a 
main effect of time.  Tracer-to-tracee ratios of C18:0 at 6 (0.12 ± 0.02), 12 (0.12 ± 0.02), 
and 24 h (0.17 ± 0.02) time points following the addition of label were greater (P < 
0.001) than TTRC18:0 at 0 h (0.00 ± 0.02), but not different from each other.  For TTRC18:1 
cis-9, there was significant interaction (P < 0.01) between level of palmitoleic acid 
supplementation and time of incubation with 1-
13
C18:0.  Enrichment of C18:1 cis-9 was 
first detected at 12 h for 0 M palmitoleic acid treated cells and at 24 h for 150 M 
palmitoleic acid treated cells (Figure 4).  At 24 h when enrichment was above 
background for both levels of palmitoleic acid, TTRC18:1 cis-9 was greater (P < 0.001) in 0 
M palmitoleic acid cells than in 150 M palmitoleic acid-treated cells.  Similarly, the 
desaturation rate, calculated as FSRC18:1 cis-9 from 0 to 24 h following the addition of 1-
13
C18:0, was reduced by more than 70% in cells supplemented with palmitoleic acid.   
Gene Expression. Fatty acid synthase mRNA was down-regulated (P < 0.01) by 




300 M palmitoleic acid, FASN mRNA expression was not different (P > 0.05) from 
control (0 M). Gene expression of ACC was not different (P < 0.05) in palmitoleic acid-
supplemented cells compared to controls.  Both ACC and FASN are key enzymes in de 
novo fatty acid synthesis. Fatty acid synthesis begins with the committed step of adding a 
carboxyl group to acetyl-CoA, forming malonyl-CoA, by ACC, which can be regulated 
allosterically, by phosphorylation, and transcriptionally.  Fatty acid synthase is a large, 
multimeric protein that sequentially adds acetate to malonyl-CoA or a fatty acyl-CoA 
until the fatty acid reaches a length of 16 carbons, C16:0.  Changed in FASN gene 
expression with palmitoleic acid supplementation followed a similar pattern as rate of 
lipogenesis using 
13
C2; however, gene expression was unchanged at 300 M but 
lipogenic rate was still reduced compared to controls.  
 Expression of SCD1 mRNA was down-regulated (P < 0.05) by 60% or more at 
all three levels of palmitoleic acid supplementation compared to control (0 M).  
Stearoyl-CoA desaturase is the enzyme responsible for the desaturation of SFA to MUFA 
by inserting a double bond in the position.  As reviewed by Ntambi and Miyazaki 
(2004), SCD1 has been extensively studied especially in the murine model.  Transcription 
of SCD1 mRNA is controlled primarily by SREBP which binds to sterol response 
element in the promoter region of the SCD1 gene (Lay et al., 2002; Eberlé et al., 2004).  
The promoter region of the bovine SCD1 gene is contains a fat specific element, PUFA 
response element, and SREBP-response region (Keating et al., 2006). Expression of 
SCD1 is also regulated by its products and not by the availability of its substrates 




SCD1, also down-regulates SCD1 mRNA expression in bovine cells.  In addition, the 
MUFA/SFA ratio and FSRdesaturase show that palmitoleic acid impacts actual activity of 
the desaturase as well.  Due to the similarities between the percent decrease in desaturase 
activity and gene expression, the regulation of palmitoleic acid on SCD1 most likely 
occurs at the level of transcription; although, Cao et al. (2008) report SCD1 protein 
stability may also be affected by palmitoleic acid.  The PUFA response element in the 
bovine SCD1 promoter region is the most likely target of transcriptional repression by 
palmitoleic acid (Keating et al., 2006).  In a mouse reporter assay, promoter activity of 
SCD1 was suppressed by palmitoleic acid supplementation (Cao et al., 2008).  When the 
PUFA response element of the SCD1 promoter region was mutated, palmitoleic acid no 
longer suppressed SCD1 promoter activity (Cao et al., 2008).   
Several elongase enzymes are present in mammalian cells and responsible for that 
add acetyl-CoA molecules to the carboxylic acid end of a fatty acid hydrocarbon 
skeleton.  However, each elongase isoform has preferred fatty-acyl substrates of 
particular C length (Guillou et al., 2010).  In humans, most ELOVL proteins identified 
elongate PUFA greater than or equal to 18C; however, ELOVL6 is attributed to the 
conversion of 12 to 16C SFA and MUFA, including C16:1 to C18:1 cis-11 (Matsuzaka et 
al., 2002; Leonard et al., 2004).  It has been proposed that palmitoleic acid can be 
elongated into C18:1 cis-11 and potentially elongated further into a 20C fatty acid, C20:1 
cis-13 (Matsuzaka and  Shimano, 2009).  In addition, ELOVL5 is reported to have some 
activity for this reaction (Wang et al., 2006), especially in absence of ELOVL6 




et al., 2004; Wang et al., 2006), these 2 ELOVL isoforms are the only bovine elongase 
enzymes published on NCBI to date (Zimin et al., 2009).  As FASN is not capable of 
synthesizing fatty acids greater than 16C in length, acetate molecules were most likely 
added to C16:1 cis-9 by ELOVL6 in our study.  Elongation with acetate increased the 




 positions, respectively, with each 2C addition.   
In our adipocyte cultures, CPT1A mRNA was up-regulated (P < 0.05) by 
palmitoleic acid supplementation.  Carnitine palmitoyl-transferase 1A is responsible for 
transporting long chain fatty acids through the outer mitochondrial membrane for the 
purpose of -oxidation in the mitochondrial matrix.  In ruminants, CPT1A is expressed in 
numerous tissues including adipose tissue in contrast to a more restricted tissue 
abundance in monogastrics (Price et al., 2003).  Inhibition of CPT1A is primarily 
attributed to malonyl-CoA, the product of the ACC reaction, in monogastric species 
(McGarry and  Brown, 1997).  Price et al. (2003) found N-terminal sequence differences 
in ovine CPT1 that alter enzyme kinetics for certain substrates, which differs from that of 
the rat.  Palmitoleic acid supplementation stimulates CPT1A transcription which may 
lead to increase -oxidation and ATP production. 
Fatty acid synthase, ELOVL6, and SCD1 genes are all transcriptionally controlled 
by SREBP (Eberlé et al., 2004), suggesting coordinated regulation.  There was no effect 
(P > 0.05) of palmitoleic acid supplementation on SREBP gene expression (data not 
shown).  However, post-translational modification is the primary level of regulation for 




one would not expect mRNA expression of this transcription factor to be altered, even if 
the protein is regulating lipogenic genes.   
Overall, supplementation of palmitoleic acid to bovine adipocytes results in 
increased incorporation of this fatty acid and its elongation products into the adipocyte, 
which down-regulates SCD1, FASN, and ELOVL6 to decrease lipogenesis and 
desaturation and up-regulates CPT1A to increase β-oxidation. These results suggest that 
exogenous palmitoleic acid, an end-product of desaturation, acts as a regulator of 






Figure 1.  Nomarski interference contrast microscopy at 40X magnification showed 
morphological change in cells on d 2 and lipid filling in palmitoleic acid-supplemented 
cells on d 6 and d 12 post-differentiation.  Undifferentiated preadipocytes on d 2 (A) were 
stellate in appearance and cells treated with differentiation media on d 0 were round in 
shape by d 2 (B).   Cells treated with palmitoleic acid appeared to have greater lipid 





Figure 2.  Scatterplot and linear regression of total fatty acids, palmitoleic (C16:1), cis-
vaccenic (C18:1 cis-11), and eicosenoic (C20:1 cis-13) acids by level of palmitoleic acid 
supplementation.  For each of these fatty acids, there was a significant interaction of 





Figure 3.  Linoleic acid (C18:2 n-6) in bovine adipocytes supplemented with 0, 50, 150, 
or 300 M palmitoleic acid.  An interaction between level of palmitoleic acid 
supplementation and day of harvest was present (P < 0.05).  
a-d
Bars lacking a similar 




Table 1.  Main effect of level of palmitoleic acid supplementation on palmitic (C16:0), 
stearic (C18:0), oleic (C18:1 cis-9) acids, and desaturation index (C18:1 cis-9/C18:0) of 
bovine adipocytes.  
0 M 50 M 150 M 300 M SEM p -value*



























0.19   < 0.001








0.04   < 0.001
a-f
  Within a row, means without a common superscript differ (P < 0.05)
*
 Probability of type I error with null hypothesis of all treatment means being equal.
Fatty acid, 
g/well









C2 (lipogenesis) and 1-
13
C18:1 cis-9 from 1-
13
C18:0 (desaturation) in 
bovine adipocyte cultures treated with palmitoleic acid, respectively.  Molar percent 
excess (MPE) per h was calculated over a 24 h period following stable isotope addition to 
the media.  *Within a time point, palmitoleic acid-treated cells differed from 
unsupplemented cells (P < 0.05).  
a-c
Bars of the same color without a similar letter 






Figure 5.  Relative expression of lipogenic genes in cells supplemented with 0, 50, 150, 
and 300 M C16:1 to d 6 post-differentiation.  Acetyl-CoA carboxylase (ACC), fatty acid 
synthase (FASN), stearoyl-CoA desaturase 1 (SCD1), elongation of long chain fatty acids 
protein (ELOVL) 5 and 6, and carnitine palmitoyl-transferase 1A (CPT1A).  CT a values 
were normalized to glyceraldehyde-3-phosphate dehydrogenase.  *P < 0.05, Gene 
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CHAPTER 4:  PALMITOLEIC (C16:1 cis-9) AND CIS-
VACCENIC ACID (C18:1 cis-11) ALTER LIPOGENESIS IN 




Our objectives were to confirm elongation products palmitoleic acid (C16:1 cis-9) 
and determine if palmitoleic acid or its elongation products or both are responsible for 
decreased desaturation and lipogenesis rates previously observed in cultured bovine 
adipocytes supplemented with palmitoleic acid.  Stromal vascular cells were isolated 
from 3 cattle, propagated, and frozen for use in this study.  Cells were passaged 4 times, 
allowed to reach confluence, held for 2 d, and then differentiated with a standard 
hormone cocktail (d 0).  At d 2, secondary differentiation media containing 1 of 4 levels 
of fatty acid [0 μM fatty acid (control), or 150 μM palmitic (C16:0), palmitoleic, or cis-
vaccenic (C18:1 cis-11)] for 4 d.  On d 6, cells were harvested for fatty acid analysis.  In 






C18:0 on d 6 to estimate 
lipogenesis and desaturation rates and confirm elongation products of palmitoleic acid 
using gas chromatography-mass spectrometry.  Incorporation of 
13
C16:1 into cells and 
presence of 
13
C label in C18:1 cis-11 confirmed it as an elongation product of palmitoleic 
acid in bovine adipocytes.  Additionally, 
13
C label was seen in C20:1 cis-13 and CLA cis-
9, cis-11.  The rate of 
13
C16:1 elongation to 
13
C18:1 cis-11 was greater (P < 0.01) in 
control cells compared with cell supplemented with palmitoleic acid prior to d 6.  In 
addition, the elongation rate of control cells increased (P 0.05) over 36 h; whereas, 




palmitoleic acid-supplemented cells, C16:1, C18:1 cis-11, and C20:1 cis-13 were 
elevated (P < 0.05) compared with control cells.  In cis-vaccenic acid-supplemented cells, 
C18:1 cis-11 and C20:1 cis-13 were elevated (P < 0.05) compared with controls, but 




C2 was reduced (P < 0.05) in palmitoleic 
acid and cis-vaccenic acid-treated compared with control cells following 36 h incubation.  
The C18:1 cis-9/C18:0 ratio was decreased (P < 0.05) in palmitoleic acid-treated cells 
compared with all other treatments.  By 12 h of 
13
C18:0 incubation, cells supplemented 
with palmitoleic acid had reduced (P < 0.05) 
13
C18:1 cis-9 compared with all other 
treatments.  Therefore, palmitoleic acid is actively elongated in vitro and its elongation 
product, cis-vaccenic acid, can also reduce lipogenesis.  However, inhibition of 
desaturation previously reported by our lab can be directly attributed to palmitoleic acid 







Excess adipose tissue can be detrimental to human health with regard to common 
medical disorders associated with obesity.  In addition, excess adipose tissue 
accumulation in livestock animals is costly to producers as wasted feed resources and 
discounts or loss of premiums for carcass cutability.   As components of both human and 
livestock diets, fatty acids have become a recent focus in energy metabolism research.  In 
the public eye, interest in fatty acid composition of meat and milk products has increased 
in recent years with rising concerns of saturated fatty acids (SFA) in the human diet.  
Generally perceived, SFA are bad for human health; whereas, monounsaturated fatty 
acids (MUFA) and polyunsaturated fatty acids (PUFA) are beneficial. 
White adipose tissue is not longer considered an inert energy storage site, but a 
complex, metabolically active tissue (McGillis, 2005).  The functional unit of white 
adipose tissue, the adipocyte, synthesizes and stores fatty acids and secretes hormones.  
Hormones produced by adipocytes include leptin (Flier, 1998), adipokines (MacDougald 
and  Burant, 2007), and a newly, proposed class of hormone, “lipokine”, in which fatty 
acids can act as signals to other body tissues (Cao et al., 2008).  Whether as a component 
of human or livestock diets, palmitoleic acid may act to regulate metabolism.   A 
lipidomic study by Cao et al. (2008) identified palmitoleic acid (C16:1 cis-9) as another 
fatty acid that may act a hormone.  They reported palmitoleic acid functioned as a 
lipokine which increased insulin sensitivity in skeletal muscle and decreased lipogenesis 
in liver of mice.  In contrast to murine animals, cattle synthesize fatty acids de novo from 




Similarly, we found palmitoleic acid functioned to reduce de novo fatty acid synthesis 
and reduce lipogenic gene expression in cultured bovine adipocytes (Burns et al., 2010).  
Supplementing bovine adipocyte cultures with palmitoleic acid resulted increased C16:1, 
cis-vaccenic (C18:1 cis-11) and eicosenoic acid (C20:1 cis-13).  We hypothesize that 
C18:1 cis-11 and C20:1 cis-13 are being elongated from palmitoleic acid and could be 
responsible for the lipokine effects seen with palmitoleic acid supplementation in bovine 
adipocytes.  Therefore, the objectives of this study were to trace palmitoleic acid 





MATERIALS AND METHODS 
Cell Culture.  Primary bovine stromal vascular (SV) cultures were harvested from 
adipose tissue of 18 mo old Angus crossbred cattle as described by Pratt et al. (2010) 
using slight modifications of methods described by Hirai et al. (2007).  Cells were plated 




 and passaged every 2 to 4 d when 60% confluent.  Cells were 
incubated at 37°C under 5% CO2 humidified atmosphere with media [Dulbecco‟s 
modified eagles medium (DMEM) containing 10% fetal calf serum (FCS), and 2X 
antibiotic/antimycotic (AB/AM; containing 10,000 U/mL penicillin G, 10,000 g/mL 
streptomycin, and 25 g/mL amphotericin B)] replacement every 2 d.  After 4 passages, 
cell lines were stored in liquid nitrogen at 1 x 10
6
 cells/mL in freezing media (DMEM, 
20% FCS, and 10% dimethyl sulfoxide) for later use. 
Treatments.  Individual cultures from 2 animals were used in duplicate for each 





.  Cells were allowed to reach confluence, held for 2 d, and differentiated on 
d 0 with DMEM containing 5% FCS, 2X AB/AM, 2.5 g/ml insulin, 0.5 mM 2-isobutyl-
1-methylaxanthine (IBMX), 0.25 M dexamethasone (DEX), 5 M troglitazone (TRO), 
and 10 mM acetate (Hirai et al., 2007; Pratt et al., 2010).  Secondary differentiation 
media (DMEM, 5% FCS, 2X AB/AM, 2.5 g/mL insulin, 5 M TRO, and 10 mM 
acetate) was applied for 4 (d 6) along with 0 M additional fatty acids (control) or 150 
M fatty acids.  According to the objectives of the experiment, cells were either 




stable isotopes on d 6 for enzymatic activity assays.  Previously, our stromal vascular 
cultures displayed characteristic changes in morphology, lipid-filling, and adipogenic 
gene expression upon hormonal treatment, consistent with adipocyte differentiation by d 
6 (Pratt et al., 2010).   
Experiment 1.   Previously, our palmitoleic acid-treated cultures showed a 
dramatic increase in C18:1 cis-11 and C20:1 cis-13.  It has been proposed that 
palmitoleic acid can be elongated into C18:1 cis-11 and potentially elongated further into 
a 20C fatty acid (Matsuzaka and  Shimano, 2009).  To confirm C18:1 cis-11 and C20:1 
cis-13 as elongation products and to measure elongation in vitro, we added stable isotope 
labeled palmitoleic acid (150 M U-
13
C16:1) on d 6 for 0, 6, 12, 24, and 36 h to 
adipocytes cultures which had been treated until d 6 with 0 (control) or 150  
palmitoleic acid.  At harvest, cells were washed 3 times with PBS, removed with trypsin, 
and placed directly into 2:1 chloroform:methanol (vol/vol) to terminate all enzymatic 
activity.  Cellular fatty acids were extracted using Folch et al. (1957) and transmethylated 
according to Park and Goins (1994).  Fatty acid methyl esters were analyzed using an 
Agilent 6890N gas chromatograph (GC; Agilent Technologies, Inc., Santa Clara, CA) 
equipped with an Agilent 5973 mass spectrometer (MS) using a 100-m Varian CP7489 
(Varian Instruments Inc., Walnut Creek, CA) capillary column (0.25 mm i.d. and 0.20 
μm film thickness).  Samples were run in the chemical ionization mode with He as the 
carrier gas and CH4 as the reagent gas.   
Ions of mass-to-charge ratio (m/z) 268 (m) and 284 (m + 16) were selectively 




298 (m) and 312 (m + 16) were measured for C18:1 cis-11.  We calculated the relative 
abundance (RA) of labeled (m + 16) to unlabeled (m) isotopomers of C16:1 and C18:1 
cis-11.  Fatty acid enrichment was calculated as tracer-to-tracee ratio (TTR), according to 
Wolfe and Chinkes (2005).   
TTRsample   =  (RAsample – RAblank) 
Samples that were not exposed to labeled isotope served as „blanks‟.  Molar percent 
excess (MPE) of C16:1 was calculated by TTR/(TTR + 1) and fractional synthetic rate 
(FSR) of elongation was calculated from TTRC18:1cis11 and MPEC16:1.  
FSRelongation   =     TTRC18:1 cis-11, time1 – TTR C18:1 cis-11, time0  
           MPEC16:1 × (time1 – time0) 
Experiment 2.  The objective of this experiment was to determine if palmitoleic 
acid or an elongation product was responsible for changes in lipogenesis.  Therefore, we 
treated adipocytes cultures with 0 M fatty acids (control) or 150 M palmitic (C16:0), 
palmitoleic, or cis-vaccenic acids on d 2 to d 6.  Fatty acid methyl esters (FAME) were 
prepared from cultures on d 6 as stated above for analysis with an Agilent 6850 GC 
equipped with an Agilent 7673A automatic sampler.  Separations were accomplished 
using a 100-m Supelco SP-2560 (Supelco, Inc., Bellefonte, PA) capillary column (0.25 
mm i.d. and 0.20 m film thickness) according to Duckett et al. (2002).  Individual fatty 
acids were identified by comparison of retention times with standards (Sigma, St. Louis, 
MO; Matreya, Pleasant Gap, PA).  Fatty acids were quantified by incorporating an 
internal standard, methyl tricosanoic (C23:0) acid, into each sample during methylation 




Lipogenesis.  To measure lipogenesis in vitro, we substituted unlabeled acetate in 
the culture media on d 6 with stable isotope labeled acetate (10 mM 1-
13
C2) to cultures 
treated with 0 M fatty acids (control) or 150 M palmitoleic or cis-vaccenic acid for 0, 
12, 24, and 36 h.  Cells were harvested and FAME prepared as described above.  Ions of 
mass-to-charge ratio (m/z) 270 (m), 271 (m + 1), and 272 (m + 2) were selectively 
measured to calculate the isotopic enrichments of C16:0, the primary product of de novo 
lipogenesis.   
The formation of a fatty acid polymer, C16:0, from repeating units of acetate is an 
ideal application of Mass Isotopomer Distribution Analysis (MIDA; Wolfe and  Chinkes, 
2005).  Therefore, we used this approach to estimate enrichment in our precursor pool 
and calculate FSR of lipogenesis.  First, we calculated RA of singly (m + 1) and doubly 
(m + 2) labeled C16:0 to unlabeled (m) C16:0 isotopomers.  To account for background 
noise and natural abundance of 
13
C isotope when using a singly-labeled tracer, the 
enrichment of C16:0 was calculated as TTRC16:0 = (RAsample – RAblank) * (1 – A)
n 
, where 
A was the natural abundance of 
13
C, A = 0.011, and n was the number of C in the fatty 
acid molecule, n = 16 (Wolfe and  Chinkes, 2005).  Samples that were not exposed to 
labeled isotope served as „blanks‟.  Precursor enrichment in molar percent excess (MPE) 
was estimated by: 
 
MPEprecursor     =             2 × (TTR(m + 2) / TTR(m + 1)) 
       (p – 1) + (2 × (TTR(m + 2) / TTR(m + 1)) 
where, p is the number of precursor monomers present in the polymer, p = 8.  Finally, our 




FSRlipogenesis   =                        TTRC16:0, time1 – TTRC16:0, time0 
     (p × MPEprecursor) (1 - MPEprecursor)
p-1
 (time1 – time0) 
Desaturation.  Stearoyl-CoA desaturase 1 (SCD1) is the enzyme responsible for 
creating a double bond at the 
9
 position of several fatty-acyl CoA and its preferred 
substrates are C16:0 and C18:0 (Enoch et al., 1976).  Its transcription and activity can 
regulated by certain fatty acids (Ntambi, 1995), including palmitoleic acid (Burns et al., 
2010).   In order to measure desaturation rates in vitro, we added 100 M U-
13
C18:0 to 
cultures treated with 0 M fatty acid (control) or 150 M palmitic, palmitoleic, or cis-
vaccenic acid on d 6 for 0, 12, and 24 h.  Samples were prepared and analyzed as 
described above for analysis with GC-MS.  Ions of mass-to-charge ratio (m/z) 298 (m) 
and 316 (m + 18) were selectively measured to calculate the isotopic enrichments of 
C18:0.  Similarly, isotope abundance of 296 (m) and 314 (m + 18) was measured for 
C18:1 cis-9.  Since tracer enrichment can be measured in this case and the product of the 
SCD reaction is not a polymer of the tracer, it was not necessary to use MIDA.  The FSR 
was calculated for rate of desaturation using the precursor enrichment, MPEC18:0. 
FSRdesaturation   =    TTRC18:1 cis-9, time1 – TTR C18:1 cis-9, time0  
           MPEC18:0 × (time1 – time0) 
Gene Expression.  Total cellular RNA was isolated from cells using the mirVana 
microRNA Isolation kit (Ambion, Austin, TX) according to manufacturer‟s instructions 
and RNA quality as described by Duckett et al. (2009).  Quality was assessed using 
Nanodrop 2000 Spectrophotometer (Thermo Fisher Scientific, Inc., Waltham, MA) and 




absorbance ratio > 1.9 on the Nanodrop and RNA integrity number > 9.0 (1.0 to 10.0 
scale) using Agilent RNA 6000 Nano kit.  Superscript III reverse transcriptase 
(Invitrogen Corp., Carlsbad, CA) was used to synthesize first strand cDNA.  Real-time 
PCR was conducted using an Eppendorf MasterCycler ep realplex (Westbury, NY) with 
the QuantiTect SYBR Green RT-PCR Two Step Kit (Qiagen, Valencia, CA) according to 
the manufacturer‟s directions.  Two genes, glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) and β-actin, were evaluated as housekeeping genes for data normalization 
(Duckett et al., 2009).  To determine the appropriate housekeeping gene to be used to 
normalize the data, the cycle threshold values (CT) for GAPDH, β-actin, and all target 
genes per sample were entered into the BESTKEEPER program (http://www.gene-
quantification.info). The program determines the most stable housekeeping gene to be 
used for normalization by repeated pair-wise correlation and regression analysis (Pfaffl et 
al., 2002). Both GAPDH and β-actin exhibited a correlation coefficient of 0.99 (P < 
0.001) in the analysis and were suitable for data normalization.  Primers for bovine 
mRNAs were designed using Primer 3 software (http://frodo.wi.mit.edu/primer3/).  
Primer sets were first evaluated according to Duckett et al. (2009) to verify identity.   
Genes of interest for this study were those involved in fatty acid biosynthesis including 
acetyl-CoA carboxylase (ACC), fatty acid synthase (FASN), fatty acid elongase 
(ELOVL) -5 and -6, SCD1, sterol regulatory element binding protein-1c (SREBP), and 
carnitine palmitoyl-transferase 1A (CPT1A).  
Statistical Analysis.  The data were analyzed using Proc GLM procedure of SAS 




analysis of variance (ANOVA) was performed as a completely randomized design with 
factors fatty acid (control, palmitic, palmitoleic, and cis-vaccenic), time (0, 12, 24, and 36 
h), and two-way interaction.  Least squares means were computed and separated 
statistically using Fisher‟s Protected LSD test.  Relative gene expression data was 
analyzed using Pair-wise Fixed Reallocation Randomization Test (Pfaffl et al., 2002) 




RESULTS AND DISCUSSION 
Experiment 1.  Incubating bovine adipocytes with U-
13
C16:1 resulted in 
enrichment (P < 0.001) of C16:1 and C18:1 cis-11 fatty acids over time.  Tracer-to-tracee 
ratio of C16:1 was greater than zero (P < 0.01) 6 h after U-
13
C16:1 addition to the media 
and remained elevated (P < 0.01) to 36 h (Figure 1).  Enrichment of C18:1 cis-11 as TTR 
was also greater than zero (P < 0.05) by 6 h and continued to increase (P < 0.01) above 6 
h levels at 24 and 36 h.  The presence of tracer definitively shows that C16:1 is taken in 
by bovine adipocytes and elongated to C18:1 cis-11 in palmitoleic acid-supplemented 
cells.  When adipocytes were exposed to unlabeled palmitoleic acid from d 2 to d 6 and 
U-
13
C16:1 on d 6, the FSRelongation did not change (P > 0.05) over the 36 h period and was 
lower (P < 0.01) throughout the period compared with control cells.  The FSRelongation 
increased (P < 0.05) over the 36 h period in control adipocytes, those cells which were 
newly exposed to palmitoleic acid (Figure 1).   
In addition to label appearing in C16:1 and C18:1 cis-11 fatty acids following 
incubation with U-
13
C16:1, enrichment was seen in C20:1 cis-13 and CLA cis-9, cis-11 
(data not shown).  Statistical analysis was not performed because fatty acid peaks for 
C20:1 cis-13 and CLA cis-9, cis-11 were only detectable in a few samples.  However, 
when detectable, fatty acid peaks contained masses consistent with m + 16 enrichment 
from U-
13
C16:1.  The formation of these fatty acids is possible through established fatty 
acid pathways.  Once palmitoleic acid is elongated to C18:1 cis-11, it can be further 




Experiment 2.  We successfully incorporated our fatty acid supplements into 
bovine adipocyte cultures based on detection of increased levels (P < 0.01) of treatment 
fatty acids in cells after all media was removed.  Comparing fatty acid data between 
control, palmitic, palmitoleic, and cis-vaccenic acid-treated cells, there was a main effect 
of fatty acid treatment (P < 0.01) for total fatty acids (Table 1).  Micrograms of total fatty 
acids were greatest (P < 0.001) in palmitoleic and cis-vaccenic acid-treated cells at about 
2X greater than control cells (Table 1).  Palmitic acid-treated cells also had higher (P < 
0.05) levels of total fatty acids compared with controls, but lower (P < 0.05) than 
palmitoleic and cis-vaccenic acid-treated cells, despite being supplemented at the same 
level.  Reduced total fatty acids in palmitic acid-treated cells compared with MUFA-
treated cells is most likely due to an apoptitic effect of palmitic acid supplementation.  In 
murine adipocytes, palmitic acid induces apoptosis (Guo et al., 2007).  Similarly, we 
suspected that palmitic acid-supplementation in our bovine adipocyte cultures induced 
apoptosis, resulting in reduced total lipid accumulation and treatment fatty acid inclusion 
compared with MUFA-supplemented cells.  To test this hypothesis, we treated 
differentiated adipocytes with palmitic and palmitoleic acid to d 6 and assayed cell 
viability using Cell Counting Kit-8 (Dojindo Molecular Technologies, Inc., Rockville, 
MD) according to manufacturer‟s instructions.  Relative cell viability was greater (P < 
0.05) for palmitoleic acid-treated cells compared with palmitic acid-treated cells (data not 
shown).  Despite a reduction in cell viability, palmitic acid-treated cells had increased (P 
< 0.05) levels of C16:0, C18:0, C18:1 cis-9, and C18:2n-6 compared with all other 




Palmitoleic acid-treated cells had increased (P < 0.05) levels of C16:1 compared 
with all other treatment groups.  In addition, palmitoleic acid cells had increased (P < 
0.05) levels of C18:1 cis-11 and C20:1 cis-13 compared with controls, consistent with 
results from our previous work .  Cis-vaccenic acid-supplemented cells had slightly 
elevated (P < 0.05) C16:1 compared with controls, but were not different (P > 0.05) than 
palmitic acid-treated cells.  Also, cis-vaccenic acid-supplemented cells had the greatest 
(P < 0.05) amount of C18:1 cis-11 and C20:1 cis-13 compared with all other treatment 
groups.   
Palmitic acid-treated cells had the greatest (P < 0.05) levels of C18:0, C18:1 cis-9, 
and C18:2n-6 levels compared with all other treatment groups (Table 1).  Palmitoleic and 
cis-vaccenic acid-treated cells had the lowest (P < 0.05) levels of C18:1 cis-9 and 
C18:2n-6 fatty acids.  Despite low levels of C18:1 cis-9 in both MUFA-treated groups, 
the desaturation index of C18:1 cis-9/C18:0 was reduced (P < 0.05) in palmitoleic acid 
treated cells only compared will all other treatment groups (Table 1).  The desaturation 
index of C18:1 cis-9/C18:0 indicates desaturase activity was only impacted by 
palmitoleic acid supplementation, not cis-vaccenic acid.  However, supplementation of 
either MUFA in adipocyte cultures probably resulted in altered fatty acid metabolism of 
long chain-PUFA, as C18:2n-6 was decreased (P < 0.05) in both groups compared with 
controls and C20:4n-6 tended (P = 0.07) to be lower.   
Lipogenesis.  Precursor enrichment, MPEacetate, did not change (P > 0.05) over 
time or due to treatment in our cultures using MIDA, nor was there a time by treatment 




al., 1999).  There was an interaction (P < 0.01) between fatty acid treatment and length of 
13
C2 incubation on C16:0 enrichment.  The TTRC16:0 did not differ (P > 0.05) between 
treatment groups at 0 h and increased (P < 0.05) in all groups over time.  At 24 and 36 h 
time points, TTRC16:0 was decreased (P < 0.05) in palmitoleic and cis-vaccenic-treated 
cells compared with controls.  The FSRlipogenesis, calculated from MPEprecursor  and 
TTRC16:0, also shows a reduction in lipogenesis in palmitoleic and cis-vaccenic acid-
treated cells.  The FSRlipogenesis was decreased (P < 0.01) in MUFA-treated cells compared 
with controls between the 24 and 36 h time points and was numerically lower between 0 
to 12 h and 12 to 24 h time points (Figure 2).  Palmitoleic acid-treated cells tended to 
have a lower (P = 0.07) FSRlipogenesis between 0 and 12 h time points.  Reduced 
lipogenesis in palmitoleic acid-treated cultures is consistent with our previous results 
when we supplemented 150 M palmitoleic acid, which resulted in approximately 45% 
reduction in lipogenesis.  In this case, both MUFA induced a repressive effect on 
lipogenesis of approximately the same magnitude.  Therefore, this effect of palmitoleic 
acid supplementation on lipogenesis cannot be directly attributed to palmitoleic acid as its 
elongated form, cis-vaccenic acid, also displayed anti-lipogenic effects.  
Desaturation.  Because the desaturation index of C18:1 cis-9/C18:0 is not always 
accurate (Archibeque et al., 2005), we supplemented a labeled substrate of the SCD1 
reaction (U-
13
C18:0) to our bovine adipocyte cultures to serve as a measurement of 
desaturase activity.  There was a treatment by length of incubation interaction for 
precursor enrichment, TTRC18:0.  It was not different (P > 0.05) than zero at 0 h, but 




differential incorporation of labeled U-
13
C18:0 into the different treatment groups.  Cells 
treated with palmitoleic and cis-vaccenic acids had increased (P < 0.01) TTRC18:0 
compared with control and palmitic acid-treated cells (Figure 3).  There was also a 
treatment by incubation time interaction (P < 0.01) for TTRC18:1 cis-9.  At 0 h, there was no 
enrichment (P > 0.05) of C18:1 cis-9 in any treatment group; by 12 h, TTRC18:1 cis-9 was 
still not different than zero in palmitoleic acid-treated cells (P < 0.01).  However, control, 
palmitic, and cis-vaccenic acid-treated cells did not differ (P > 0.05) from each other and 
were enriched (P < 0.05) with C18:1 cis-9 at 12 h.  By 24 h, all treatment groups differed 
(P < 0.05) from each other and had enrichment (P < 0.05) of C18:1 cis-9.  Palmitoleic 
acid-treated cells had reduced (P < 0.01) TTRC18:1 cis-9 compared to controls, palmitic, and 
cis-vaccenic acid treated cells at 12 and 24 h.  Palmitic and cis-vaccenic acid-treated cells 
had lower (P < 0.05) TTRC18:1 cis-9  at 24 h than controls, but higher (P < 0.05) than 
palmitoleic acid-treated cells.  Despite increased TTRC18:0 in palmitoleic and cis-vaccenic 
acid-treated cells, they still showed less formation of the desaturase product, C18:1 cis-9.    
The isotopic measure of SCD1 activity, FSRdesaturation, showed a more dramatic 
effect of fatty acid supplementation on desaturase activity than the C18:1 cis-9/C18:0 
desaturation index results.  The FSRdesaturation over 0 to 12 h was decreased (P < 0.01) in 
palmitoleic acid-treated cells compared with all other treatment groups, which did not 
differ (P > 0.05) from each other (Figure 3).  From 12 to 24 h, however, all treatment 
groups had a different FSRdesaturation.  Palmitic acid-treated cells had the highest (P < 0.01) 
rate of desaturation and palmitoleic acid-treated cells had the lowest (P < 0.01) 




palmitoleic acid was approximately 100% from 0 to 12 h and approximately 60% from 
12 to 24 h.  By contrast, palmitoleic acid reduced the desaturation index by less than 25% 
compared with controls (Table 1).  The FSRdesaturation also showed a reduction in SCD1 
activity by approximately 15% from 12 to 24 h due to cis-vaccenic acid (Figure 3), 
whereas the desaturation index for cis-vaccenic acid-treated cells was not different from 
controls.  Therefore, the FSRdesaturation is a more sensitive measurement of SCD1 activity 
than the C18:1 cis-9/C18:0 desaturation index when fatty acids are supplemented to 
adipocyte cultures.  
Gene Expression.  The genes that primarily involved in de novo lipogenesis are 
ACC and FASN.  In this study, palmitic acid-treated cells did not differ (P > 0.05) from 
control cultures for ACC or FASN mRNA expression.  Acetyl-CoA carboxylase was up-
regulated (P < 0.05) in response to both palmitoleic and cis-vaccenic acid 
supplementation compared with controls (Figure 4).  In contrast, FASN was down-
regulated (P < 0.05) by both MUFA.  These 2 results are seemingly contradictory.  
However, ACC activity can be regulated also be regulated allosterically and through 
phosphorylation.  Regulated by the transcription factor SREBP, FASN gene expression 
was reduced by approximately 40%, similar to FSRlipogenesis results.     
Transcription of SCD1 mRNA is controlled primarily by SREBP, which binds to 
sterol response element in the promoter region of the SCD1 gene (Eberle et al., 2004; Lay 
et al., 2002).  In our study, SREBP mRNA was down-regulated (P < 0.05) in only 
palmitic acid-treated cells compared with controls.  The promoter region of the bovine 




response region (Keating et al., 2006).  In addition to PUFA, expression of SCD1 is also 
regulated by its products and not by the availability of its substrates (Keating et al., 
2006).  For instance, the addition of C18:1 cis-9 and CLA cis-9, trans-11 reduced SCD 
promoter activity, but C18:1 trans-11 did not (Keating et al., 2006).  Our study confirmed 
that palmitoleic acid, and not cis-vaccenic acid, acts to down-regulates (P < 0.05) SCD1 
gene expression in bovine cells (Figure 4).  Palmitic acid-treated cells were not different 
(P > 0.05) from controls in SCD1 mRNA expression.  Both the desaturase index and 
FSRdesaturase confirm that palmitoleic acid impacts actual activity of the enzyme, not just 
gene expression; whereas, cis-vaccenic acid induces a minimal response in rate of 
desaturation with no effect on the desaturation index or gene expression and palmitic acid 
increases the rate of desaturation with no effect on the desaturation index.   
Several elongase enzymes are present in mammalian cells and are responsible for 
adding acetyl-CoA molecules to the carboxylic acid end of a fatty acid hydrocarbon 
skeleton.  Each elongase isoform has preferred fatty-acyl substrates of particular C length 
(Guillou et al., 2010).  In humans, most ELOVL proteins identified are responsible for 
elongating PUFA greater than or equal to 18C; however, ELOVL6 is attributed to the 
conversion of 12 to 16C SFA and MUFA, including C16:1 to C18:1 cis-11 (Matsuzaka et 
al., 2002; Leonard et al., 2004).  It has been proposed that C16:1 cis-9 can be elongated 
into C18:1 cis-11 and potentially elongated further into a 20C fatty acid, C20:1 cis-13 
(Matsuzaka and  Shimano, 2009).  In addition, ELOVL5 is reported to have some activity 
for this reaction (Wang et al., 2006), especially in absence of ELOVL6 (Matsuzaka et al., 




acetate molecules were most likely added to C16:1 cis-9 by either ELOVL5 or -6 in our 
study.  Primarily regulated by lipogenic transcription factors (Leonard et al., 2004; Wang 
et al., 2006), these 2 ELOVL isoforms are the only bovine elongase enzymes published 
on NCBI to date (Zimin et al., 2009).  Transcription factors that regulate ELOVL6 
include SREBP-1c and peroxisome proliferator-activated receptor  (PPAR ); ELOVL5 
expression is up-regulated PPAR  and not by SREBP-1c (Wang et al., 2006).  In our 
study, expression of ELOVL6 was down-regulated (P < 0.05) with palmitic, palmitoleic, 
and cis-vaccenic acid supplementation; however, ELOVL5 expression was up-regulated 
(P < 0.05) with MUFA treatments (Figure 4).  Palmitic acid-treated cells had numerically 
lower ELOVL5 mRNA expression compared with controls.   
In our adipocyte cultures, CPT1A mRNA was up-regulated (P < 0.05) by all fatty 
acid treatments and tended (P = 0.10) to be highest in palmitoleic acid-treated cells.  
Carnitine palmitoyl-transferase 1A is responsible for transporting long chain fatty acids 
through the outer mitochondrial membrane for the purpose of -oxidation in the 
mitochondrial matrix.  In ruminants, CPT1A is expressed in numerous tissues including 
adipose tissue in contrast to a more restricted tissue abundance in monogastrics (Price et 
al., 2003).  Inhibition of CPT1A is primarily attributed to malonyl-CoA, the product of 
the ACC reaction, in monogastric species (McGarry and  Brown, 1997).  Price et al. 
(2003) found N-terminal sequence differences in ovine CPT1 that alter enzyme kinetics 
for certain substrates, which differs from that of the rat.  Palmitoleic acid 
supplementation stimulates CPT1A transcription which may lead to increase -oxidation 




In this study, we confirmed C18:1 cis-11 and C20:1 cis-13 as products of 
palmitoleic acid elongation in vitro and that CLA cis-9, cis-11 can also be produced 
through elongation and desaturation of palmitoleic acid.  Palmitoleic acid and cis-
vaccenic supplementation reduces lipogenesis and FASN gene expression.  However, 
palmitoleic acid only reduces SCD1 gene expression and desaturation activity.  
Therefore, palmitoleic acid is actively elongated in vitro and its elongation product, cis-






Figure 1.  Elongation of C16:1 to C18:1 cis-11 in bovine adipocyte cultures.  Tracer-to-
tracee ratio (TTR) of C16:1 and C18:1 cis-11 in displayed over time in control cells after 
150 M U-
13
C16:1 addition.  Fractional synthetic rate of 
13
C18:1 cis-11 from 
13
C16:1 in 
cells treated with 0 M (control) or 150 M palmitoleic acid until d 6 displayed as molar 
percent excess (MPE) per h and was calculated over a 36 h period following stable 
isotope administration.  
a-c
Time points without a common letter differed (P < 0.05).  




Table 1.  Fatty acid composition of bovine adipocyte cultures treated with 0 M fatty 
acids (control), 150 M palmitic, palmitoleic, or cis-vaccenic acid. 
 
































































C20:4n-6 6.42 6.65 6.11 5.84 0.15 0.0676



























ND, fatty acid not detected
a-d







Figure 2.   Lipogenesis in bovine adipocyte cultures treated with 0 M fatty acid 
(control), 150 M palmitoleic or cis-vaccenic acid.  Estimation of molar percent excess 
(MPE) of acetate after 1-
13
C2 addition to the media.  Enrichment of C16:0 displayed as 





displayed as molar percent excess (MPE) per h calculated over a 36 h period following 
stable isotope administration.  *Within a time point, fatty acid-treated cells differed (P < 





Figure 3.  Desaturation of C18:0 to C18:1 cis-9 in bovine adipocyte cultures treated with 
0 M fatty acids (control), 150 M palmitic, palmitoleic, or cis-vaccenic acid.  Tracer-to-
tracee ratio (TTR) of C18:0 and C18:1 cis-9 displayed over time following 100 M U-
13
C18:0 addition to the media.  Fractional synthetic rate of 
13
C18:1 cis-9 from 
13
C18:0 
displayed as molar percent excess (MPE) per h calculated over a 24 h period following 
stable isotope administration.  *Within a time point, fatty acid-treated cells differed (P < 





Figure 4.  Relative expression of genes associated with lipogenesis in bovine adipcytes 
supplemented with 0 M fatty acids (control) or 150 M palmitic, palmitoleic or cis-
vaccenic acid.  Acetyl-CoA carboxylase (ACC), fatty acid synthase (FASN), stearoyl-
CoA desaturase 1 (SCD1), fatty acid elongase (ELOVL)-5 and -6, sterol response 
element binding protein-1c (SREBP), and carnitine-palmitoyl transferase 1A (CPT1A) 
were up-regulated in adipcytes exposed to MUFA supplements.  All CT values were 
normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH).   *Gene expression 
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